1
|
Nakao M, Ozawa S, Miura H, Yamada K, Hayata M, Hayashi K, Kawahara D, Nakashima T, Ochi Y, Okumura T, Kunimoto H, Kawakubo A, Kusaba H, Nozaki H, Habara K, Tohyama N, Nishio T, Nakamura M, Minemura T, Okamoto H, Ishikawa M, Kurooka M, Shimizu H, Hotta K, Saito M, Nakano M, Tsuneda M, Nagata Y. CT number calibration audit in photon radiation therapy. Med Phys 2024; 51:1571-1582. [PMID: 38112216 DOI: 10.1002/mp.16887] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2023] [Revised: 06/29/2023] [Accepted: 11/26/2023] [Indexed: 12/21/2023] Open
Abstract
BACKGROUND Inadequate computed tomography (CT) number calibration curves affect dose calculation accuracy. Although CT number calibration curves registered in treatment planning systems (TPSs) should be consistent with human tissues, it is unclear whether adequate CT number calibration is performed because CT number calibration curves have not been assessed for various types of CT number calibration phantoms and TPSs. PURPOSE The purpose of this study was to investigate CT number calibration curves for mass density (ρ) and relative electron density (ρe ). METHODS A CT number calibration audit phantom was sent to 24 Japanese photon therapy institutes from the evaluating institute and scanned using their individual clinical CT scan protocols. The CT images of the audit phantom and institute-specific CT number calibration curves were submitted to the evaluating institute for analyzing the calibration curves registered in the TPSs at the participating institutes. The institute-specific CT number calibration curves were created using commercial phantom (Gammex, Gammex Inc., Middleton, WI, USA) or CIRS phantom (Computerized Imaging Reference Systems, Inc., Norfolk, VA, USA)). At the evaluating institute, theoretical CT number calibration curves were created using a stoichiometric CT number calibration method based on the CT image, and the institute-specific CT number calibration curves were compared with the theoretical calibration curve. Differences in ρ and ρe over the multiple points on the curve (Δρm and Δρe,m , respectively) were calculated for each CT number, categorized for each phantom vendor and TPS, and evaluated for three tissue types: lung, soft tissues, and bones. In particular, the CT-ρ calibration curves for Tomotherapy TPSs (ACCURAY, Sunnyvale, CA, USA) were categorized separately from the Gammex CT-ρ calibration curves because the available tissue-equivalent materials (TEMs) were limited by the manufacturer recommendations. In addition, the differences in ρ and ρe for the specific TEMs (ΔρTEM and Δρe,TEM , respectively) were calculated by subtracting the ρ or ρe of the TEMs from the theoretical CT-ρ or CT-ρe calibration curve. RESULTS The mean ± standard deviation (SD) of Δρm and Δρe,m for the Gammex phantom were -1.1 ± 1.2 g/cm3 and -0.2 ± 1.1, -0.3 ± 0.9 g/cm3 and 0.8 ± 1.3, and -0.9 ± 1.3 g/cm3 and 1.0 ± 1.5 for lung, soft tissues, and bones, respectively. The mean ± SD of Δρm and Δρe,m for the CIRS phantom were 0.3 ± 0.8 g/cm3 and 0.9 ± 0.9, 0.6 ± 0.6 g/cm3 and 1.4 ± 0.8, and 0.2 ± 0.5 g/cm3 and 1.6 ± 0.5 for lung, soft tissues, and bones, respectively. The mean ± SD of Δρm for Tomotherapy TPSs was 2.1 ± 1.4 g/cm3 for soft tissues, which is larger than those for other TPSs. The mean ± SD of Δρe,TEM for the Gammex brain phantom (BRN-SR2) was -1.8 ± 0.4, implying that the tissue equivalency of the BRN-SR2 plug was slightly inferior to that of other plugs. CONCLUSIONS Latent deviations between human tissues and TEMs were found by comparing the CT number calibration curves of the various institutes.
Collapse
Affiliation(s)
- Minoru Nakao
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
| | - Shuichi Ozawa
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
| | - Hideharu Miura
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
| | - Kiyoshi Yamada
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
| | - Masahiro Hayata
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
| | - Kosuke Hayashi
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
| | - Daisuke Kawahara
- Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
| | - Takeo Nakashima
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Radiation Therapy Section, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan
| | - Yusuke Ochi
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Radiation Therapy Section, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan
| | - Takuro Okumura
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Radiation Therapy Section, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan
| | - Haruhide Kunimoto
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Radiation Therapy Department, Hiroshima Prefectural Hospital, Hiroshima, Japan
| | - Atsushi Kawakubo
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Radiation Therapy Department, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan
| | - Hayate Kusaba
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Radiation Therapy Department, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan
| | - Hiroshige Nozaki
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Division of Radiology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan
| | - Kosaku Habara
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Division of Radiology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan
| | - Naoki Tohyama
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Division of Medical Physics, Tokyo Bay Makuhari Clinic for Advanced Imaging, Cancer Screening, and High-Precision Radiotherapy, Chiba, Japan
| | - Teiji Nishio
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Medical Physics Laboratory, Division of Health Science, Graduate School of Medicine, Osaka University, Osaka, Japan
| | - Mitsuhiro Nakamura
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Department of Radiation Oncology and Image-Applied Therapy, Kyoto University, Kyoto, Japan
- Department of Advanced Medical Physics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Toshiyuki Minemura
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Division of Medical Support and Partnership, Institute for Cancer Control, National Cancer Center, Tokyo, Japan
| | - Hiroyuki Okamoto
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, Tokyo, Japan
| | - Masayori Ishikawa
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Faculty of Health Sciences, Hokkaido University, Hokkaido, Japan
| | - Masahiko Kurooka
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Department of Radiation Therapy, Tokyo Medical University Hospital, Tokyo, Japan
| | - Hidetoshi Shimizu
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Aichi, Japan
| | - Kenji Hotta
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Radiation Safety and Quality Assurance division, National Cancer Center Hospital East, Chiba, Japan
- Particle Therapy Division, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan
| | - Masahide Saito
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Department of Radiology, University of Yamanashi, Yamanashi, Japan
| | - Masahiro Nakano
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Department of Radiation Oncology, Kitasato University School of Medicine, Kanagawa, Japan
| | - Masato Tsuneda
- Medical Physics Working Group in Japan Clinical Oncology Group - Radiation Therapy Study Group, Tokyo, Japan
- Graduate School of Medicine, Chiba University, Chiba, Japan
| | - Yasushi Nagata
- Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
- Department of Radiation Oncology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
- Technical Support Working Group in Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan
| |
Collapse
|
2
|
He B, Kram V, Furusawa T, Duverger O, Chu E, Nanduri R, Ishikawa M, Zhang P, Amendt B, Lee J, Bustin M. Epigenetic Regulation of Ameloblast Differentiation by HMGN Proteins. J Dent Res 2024; 103:51-61. [PMID: 37950483 PMCID: PMC10850876 DOI: 10.1177/00220345231202468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2023] Open
Abstract
Dental enamel formation is coordinated by ameloblast differentiation, production of enamel matrix proteins, and crystal growth. The factors regulating ameloblast differentiation are not fully understood. Here we show that the high mobility group N (HMGN) nucleosomal binding proteins modulate the rate of ameloblast differentiation and enamel formation. We found that HMGN1 and HMGN2 proteins are downregulated during mouse ameloblast differentiation. Genetically altered mice lacking HMGN1 and HMGN2 proteins show faster ameloblast differentiation and a higher rate of enamel deposition in mice molars and incisors. In vitro differentiation of induced pluripotent stem cells to dental epithelium cells showed that HMGN proteins modulate the expression and chromatin accessibility of ameloblast-specific genes and affect the binding of transcription factors epiprofin and PITX2 to ameloblast-specific genes. Our results suggest that HMGN proteins regulate ameloblast differentiation and enamel mineralization by modulating lineage-specific chromatin accessibility and transcription factor binding to ameloblast regulatory sites.
Collapse
Affiliation(s)
- B. He
- Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
- Craniofacial Anomalies and Regeneration Section, National Institute of Dental and Craniofacial Research, Bethesda, MD, USA
| | - V. Kram
- Molecular Biology of Bones & Teeth Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
| | - T. Furusawa
- Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
| | - O. Duverger
- Craniofacial Anomalies and Regeneration Section, National Institute of Dental and Craniofacial Research, Bethesda, MD, USA
| | - E.Y. Chu
- Department of General Dentistry, Operative Division, University of Maryland, School of Dentistry, Baltimore, MD, USA
| | - R. Nanduri
- Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
| | - M. Ishikawa
- Department of Pathology and Laboratory Medicine and Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
| | - P. Zhang
- Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
| | - B.A. Amendt
- Department of Anatomy and Cell Biology, and the Craniofacial Anomalies Research Center, Carver College of Medicine, the University of Iowa, Iowa City, IA, USA
| | - J.S. Lee
- Craniofacial Anomalies and Regeneration Section, National Institute of Dental and Craniofacial Research, Bethesda, MD, USA
| | - M. Bustin
- Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
| |
Collapse
|
3
|
Kojima H, Ishikawa M, Takigami M. Technical note: Point-by-point ion-recombination correction for accurate dose profile measurement in high dose-per-pulse irradiation field. Med Phys 2023; 50:7281-7293. [PMID: 37528637 DOI: 10.1002/mp.16641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2023] [Revised: 07/13/2023] [Accepted: 07/14/2023] [Indexed: 08/03/2023] Open
Abstract
BACKGROUND Although flattening filter free (FFF) beams are commonly used in clinical treatment, the accuracy of dose measurements in FFF beams has been questioned. Higher dose per pulse (DPP) such as FFF beams from a linear accelerator may cause problems in dose profile measurements using an ionization chamber due to the change of the charge collection efficiency. Ionization chambers are commonly used for percent depth dose (PDD) measurements. Changes of DPP due to chamber movement during PDD measurement can vary the ion collection efficiency of ionization chambers. In the case of FF beams, the DPP fluctuation is negligible, but in the case of the FFF beams, the DPP is 2.5 ∼ 4 times larger than that of the FF beam, and the change in ion collection efficiency is larger than that of the FF beam. PDD profile normalized by maximum dose depth, 10 cm depth for example, may therefore be affected by the ion collection efficiency. PURPOSE In this study, we investigate the characteristics of the ion collection efficiency change depending on the DPP of each ionization chamber in the FFF beam. We furthermore propose a method to obtain the chamber- independent PDD by applying a DPP-dependent ion recombination correction. METHODS Prior to investigating the relationship between DPP and charge collection efficiency, Jaffe-plots were generated with different DPP settings to investigate the linearity between the applied voltage and collected charge. The absolute dose measurement using eight ionization chambers under the irradiation settings of 0.148, 0.087, and 0.008 cGy/pulse were performed. Applied voltages for the Jaffe-plots were 100, 125, 150, 200, 250, and 300 V. The ion recombination correction factor Pion was calculated by the two-voltage analysis (TVA) method at the applied voltages of 300 and 100 V. The DPP dependency of the charge collection efficiency for each ionization chamber were evaluated from the DPP- Pion plot. PDD profiles for the 10 MV FFF beam were measured using Farmer type chambers (TN30013, FC65-P, and FC65-G) and mini-type chambers (TN31010, TN31021, CC13, CC04, and FC23-C). The PDD profiles were corrected with ion recombination correction at negative and positive polar applied voltages of 100 and 300 V. RESULTS From the DPP-Pion relation for each ionization chamber with DPP ranging from 0.008 cGy/pulse to 0.148 cGy/pulse, all Farmer and mini-type chambers satisfied the requirements described in AAPM TG-51 addendum. However, Pion for the CC13 was most affected by DPP among tested chambers. The maximum deviation among PDDs using eight ionization chambers for 10 MV FFF was about 1%, but the deviation was suppressed to about 0.5% by applying ion recombination correction at each depth. CONCLUSIONS In this study, the deviation of PDD profile among the ionization chambers was reduced by the ion recombination coefficient including the DPP dependency, especially for high DPP beams such as FFF beams. The present method is particularly effective for CC13, where the ion collection efficiency is highly DPP dependent.
Collapse
Affiliation(s)
- Hideki Kojima
- Department of Radiation Oncology, Sapporo Higashi Tokushukai Hospital, Sapporo, Hokkaido, Japan
| | - Masayori Ishikawa
- Faculty of Health Sciences, Hokkaido University, Sapporo, Hokkaido, Japan
| | - Makoto Takigami
- Department of Radiation Technology, KKR Sapporo Medical Center, Sapporo, Hokkaido, Japan
| |
Collapse
|
4
|
Nakamura M, Zhou D, Minemura T, Kito S, Okamoto H, Tohyama N, Kurooka M, Kumazaki Y, Ishikawa M, Clark CH, Miles E, Lehmann J, Andratschke N, Kry S, Ishikura S, Mizowaki T, Nishio T. A virtual audit system for intensity-modulated radiation therapy credentialing in Japan Clinical Oncology Group clinical trials: A pilot study. J Appl Clin Med Phys 2023:e14040. [PMID: 37191875 DOI: 10.1002/acm2.14040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2022] [Revised: 04/20/2023] [Accepted: 04/24/2023] [Indexed: 05/17/2023] Open
Abstract
PURPOSE The Medical Physics Working Group of the Radiation Therapy Study Group at the Japan Clinical Oncology Group is currently developing a virtual audit system for intensity-modulated radiation therapy dosimetry credentialing. The target dosimeters include films and array detectors, such as ArcCHECK (Sun Nuclear Corporation, Melbourne, Florida, USA) and Delta4 (ScandiDos, Uppsala, Sweden). This pilot study investigated the feasibility of our virtual audit system using previously acquired data. METHODS We analyzed 46 films (32 and 14 in the axial and coronal planes, respectively) from 29 institutions. Global gamma analysis between measured and planned dose distributions used the following settings: 3%/3 mm criteria (the dose denominator was 2 Gy), 30% threshold dose, no scaling of the datasets, and 90% tolerance level. In addition, 21 datasets from nine institutions were obtained for array evaluation. Five institutions used ArcCHECK, while the others used Delta4. Global gamma analysis was performed with 3%/2 mm criteria (the dose denominator was the maximum calculated dose), 10% threshold dose, and 95% tolerance level. The film calibration and gamma analysis were conducted with in-house software developed using Python (version 3.9.2). RESULTS The means ± standard deviations of the gamma passing rates were 99.4 ± 1.5% (range, 92.8%-100%) and 99.2 ± 1.0% (range, 97.0%-100%) in the film and array evaluations, respectively. CONCLUSION This pilot study demonstrated the feasibility of virtual audits. The proposed virtual audit system will contribute to more efficient, cheaper, and more rapid trial credentialing than on-site and postal audits; however, the limitations should be considered when operating our virtual audit system.
Collapse
Affiliation(s)
- Mitsuhiro Nakamura
- Department of Advanced Medical Physics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Dejun Zhou
- Department of Advanced Medical Physics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | | | - Satoshi Kito
- Department of Radiation Oncology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan
| | - Hiroyuki Okamoto
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, Tokyo, Japan
| | - Naoki Tohyama
- Division of Medical Physics, Tokyo Bay Makuhari Clinic for Advanced Imaging, Cancer Screening, and High-Precision Radiotherapy, Chiba, Japan
| | - Masahiko Kurooka
- Department of Radiation Therapy, Tokyo Medical University Hospital, Tokyo, Japan
| | - Yu Kumazaki
- Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
| | | | - Catharine H Clark
- National Radiotherapy Trials Quality Assurance (RTTQA) Group, Royal Surrey NHS Foundation Trust, London, UK
- Department of Radiotherapy Physics, University College London Hospital, London, UK
- Department of Medical Physics and Bioengineering, University College London, London, UK
- Medical Physics department, National Physical Laboratory (NPL), Teddington, UK
| | - Elizabeth Miles
- National Radiotherapy Trials Quality Assurance (RTTQA) Group, Mount Vernon Cancer Centre, Northwood, UK
| | - Joerg Lehmann
- Trans Tasman Radiation Oncology Group (TROG), Newcastle, Australia
- Department of Radiation Oncology, Calvary Mater Hospital, Newcastle, Australia
- School of Information and Physical Sciences, University of Newcastle, Newcastle, Australia
- Institute of Medical Physics, University of Sydney, Sydney, Australia
| | - Nicolaus Andratschke
- Department of Radiation Oncology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland
| | - Stephen Kry
- Imaging and Radiation Oncology Core (IROC), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Satoshi Ishikura
- Division of Radiation Oncology, Tokyo Bay Makuhari Clinic for Advanced Imaging, Cancer Screening, and High-Precision Radiotherapy, Chiba, Japan
| | - Takashi Mizowaki
- Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Teiji Nishio
- Medical Physics Laboratory, Division of Health Science, Graduate School of Medicine, Osaka University, Osaka, Japan
| |
Collapse
|
5
|
Miyata K, Ogawara R, Ishikawa M. Improvement of Crystal Identification Accuracy for Depth-of-Interaction Detector System with Peak-to-Charge Discrimination Method. Sensors (Basel) 2023; 23:4584. [PMID: 37430498 DOI: 10.3390/s23104584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Revised: 05/06/2023] [Accepted: 05/07/2023] [Indexed: 07/12/2023]
Abstract
In positron emission tomography (PET), parallax errors degrade spatial resolution. The depth of interaction (DOI) information provides the position in the depth of the scintillator interacting with the γ-rays, thus reducing parallax errors. A previous study developed a Peak-to-Charge discrimination (PQD), which can separate spontaneous alpha decay in LaBr3:Ce. Since decay constant of GSO:Ce depends on Ce concentration, the PQD is expected to discriminate GSO:Ce scintillators with different Ce concentration. In this study, the PQD-based DOI detector system was developed, which can be processed online and implemented in PET. A detector was composed of four layers of GSO:Ce crystals and a PS-PMT. The four crystals were obtained from both the top and bottom of ingots with a nominal Ce concentration of 0.5 mol% and 1.5 mol%. The PQD was implemented on the Xilinx Zynq-7000 SoC board with 8ch Flash ADC to gain real-time processing, flexibility, and expandability. The results showed that the mean Figure of Merits in 1D between four scintillators are 1.5, 0.99, 0.91 for layers between 1st-2nd, 2nd-3rd, and 3rd-4th respectively, and the mean Error Rate in 1D between four scintillators are 3.50%, 2.96%, 13.3%, and 1.88% for layers 1, 2, 3, and 4, respectively. In addition, the introduction of the 2D PQDs resulted in the mean Figure of Merits in 2D greater than 0.9 and the mean Error Rate in 2D less than 3% in all layers.
Collapse
Affiliation(s)
- Kento Miyata
- Graduate School of Biomedical Science and Engineering, Hokkaido University, N-15 W-7 Kita-ku, Sapporo 060-8638, Japan
| | - Ryo Ogawara
- Institute for Chemical Research, Kyoto University, Gokasho, Uji 611-0011, Japan
| | - Masayori Ishikawa
- Faculty of Health Sciences, Hokkaido University, N-12 W-5 Kita-ku, Sapporo 060-0812, Japan
| |
Collapse
|
6
|
Kon M, Okamoto H, Nakamura S, Iijima K, Chiba T, Takemori M, Nakayama H, Nakaichi T, Mikasa S, Fujii K, Urago Y, Ishikawa M, Sofue T, Katsuta S, Inaba K, Igaki H, Aso T. Planning study: prone versus supine position for stereotactic body radiotherapy in prostate by CyberKnife. J Radiat Res 2023; 64:186-194. [PMID: 36316958 PMCID: PMC9855311 DOI: 10.1093/jrr/rrac065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/11/2022] [Revised: 05/30/2022] [Indexed: 06/16/2023]
Abstract
This study aimed to clarify the differences in radiotherapy dose characteristics and delivery efficiency between the supine and prone positions in patients with prostate cancer using the CyberKnife. The planning computed tomography (CT) and delineations of the prone position were obtained by rotating the supine CT images with delineations of 180° using image processing software. The optimization parameters for planning target volume (PTV) and organs at risk (OARs) were based on the prone position. The optimization parameters determined for the prone position were applied to the supine position for optimization and dose calculation. The dosimetric characteristics of the PTV and OARs, and delivery efficiency were compared between the two different patient positions. The plans in the prone position resulted in better PTV conformity index (nCI), rectum V90%, V80%, V75%, V50% and bladder V50%. A significant difference was observed in treatment time and depth along the central axis (dCAX) between the two plans. The mean treatment time per fraction and dCAX for the supine and prone positions were 20.9 ± 1.7 min versus 19.8 ± 1.3 min (P = 0.019) and 151.1 ± 33.6 mm versus 233.2 ± 8.8 mm (P < 0.001), respectively. In this study the prone position was found to improve dosimetric characteristics and delivery efficiency compared with the supine position during prostate cancer treatment with the CyberKnife.
Collapse
Affiliation(s)
- Mitsuhiro Kon
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
- Department of Radiological Technology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Hiroyuki Okamoto
- Corresponding author. Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan 104-0045, Tokyo, Japan. Tel: +81(3)3542-2511; Fax: +81(3)3545-3567;
| | - Satoshi Nakamura
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Kotaro Iijima
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Takahito Chiba
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Mihiro Takemori
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Hiroki Nakayama
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Tetsu Nakaichi
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Shohei Mikasa
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Kyohei Fujii
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Yuka Urago
- Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Masayori Ishikawa
- Faculty of Health Sciences, Hokkaido University, North12, West5, Kita-ku, Sapporo, Hokkaido 060-0812, Japan
| | - Toshimitsu Sofue
- Department of Radiological Technology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Shoichi Katsuta
- Department of Radiological Technology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Koji Inaba
- Department of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Hiroshi Igaki
- Department of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| | - Tomohiko Aso
- Department of Radiological Technology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku Tokyo, 104-0045, Japan
| |
Collapse
|
7
|
Sasaki F, Yamashita Y, Nakano S, Ishikawa M. Verification of patient‐setup accuracy using a surface imaging system with steep measurement angle. J Appl Clin Med Phys 2022; 24:e13872. [PMID: 36537149 PMCID: PMC10113693 DOI: 10.1002/acm2.13872] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2022] [Revised: 08/15/2022] [Accepted: 11/18/2022] [Indexed: 12/24/2022] Open
Abstract
PURPOSE We evaluate an SGRT device (Voxelan HEV-600 M/RMS) installed with Radixact, with the view angle of the Voxelan's camera at 74 degrees. The accuracy of Voxelan with this steep angle was evaluated with phantom experiments and inter-fractional setup errors of patients. METHODS In the phantom experiments, the difference between the measured values of Voxelan from the truth was evaluated for translations and rotations. The inter-fractional setup error between the setup using skin markers with laser localizer (laser setup: LS) and the setup using Voxelan (surface setup: SS) was compared for head and neck (N = 19), chest (N = 7) and pelvis (N = 9) cases. The inter-fractional setup error was calculated by subtracting from bone matching by megavoltage computed tomography (MVCT) as ground truth. RESULTS From the phantom experiments, the average difference between the measured values of Voxelan from the truth was within 1 mm and 1 degree. In all cases, inter-fractional setup error based on MVCT was not significantly different between LS and SS by Welch's t-test (P > 0.05). The vector offset of the LS for head and neck, chest, and pelvis were 6.5, 9.6, and 9.6 mm, respectively, and that of the SS were 5.8, 8.6, and 12.6 mm, respectively. Slight improvement was observed for the head and neck, and chest cases, however, pelvis cases were not improved because the umbilical region could not be clearly visualized as a reference. CONCLUSION The results show that SS in Voxelan with an installation angle of 74 degrees is equal to or better than LS.
Collapse
Affiliation(s)
| | - Yuusuke Yamashita
- Graduate School of Biomedical Science and Technology Hokkaido University Sapporo Hokkaido Japan
| | | | - Masayori Ishikawa
- Faculty of Health Sciences Hokkaido University Sapporo Hokkaido Japan
| |
Collapse
|
8
|
Nakaya M, Wakamatsu M, Motegi H, Tanaka A, Sutherland K, Ishikawa M, Ozaki M, Shirato H, Hamada K, Hamada T. A real-time measurement system for gene expression rhythms from deep tissues of freely moving mice under light-dark conditions. Biochem Biophys Rep 2022; 32:101344. [PMID: 36160030 PMCID: PMC9489493 DOI: 10.1016/j.bbrep.2022.101344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2022] [Revised: 09/05/2022] [Accepted: 09/06/2022] [Indexed: 10/24/2022] Open
|
9
|
Manzi F, Ishikawa M, Di Dio C, Itakura S, Kanda T, Ishiguro H, Massaro D, Marchetti A. Infants’ Prediction of Humanoid Robot’s Goal-Directed Action. Int J Soc Robot 2022. [DOI: 10.1007/s12369-022-00941-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
AbstractSeveral studies have shown that infants anticipate human goal-directed actions, but not robot’s ones. However, the studies focusing on the robot goal-directed actions have mainly analyzed the effect of mechanical arms on infant’s attention. To date, the prediction of goal-directed actions in infants has not yet been studied when the agent is a humanoid robot. Given this lack of evidence in infancy research, the present study aims at analyzing infants’ action anticipation of both a human’s and a humanoid robot’s goal-directed action. Data were acquired on thirty 17-month-old infants, watching four video clips, where either a human or a humanoid robot performed a goal-directed action, i.e. reaching a target. Infants looking behavior was measured through the eye-tracking technique. The results showed that infants anticipated the goal-directed action of both the human and the robot and there were no differences in the anticipatory gaze behavior between the two agents. Furthermore, the findings indicated different attentional patterns for the human and the robot, showing a greater attention paid to the robot's face than the human’s face. Overall, the results suggest that 17-month-old infants may infer also humanoid robot’ underlying action goals.
Collapse
|
10
|
Chiba G, Handa H, Ishikawa M. Improvement and benchmarking of the deterministic transport calculation code CBZ to design beam shaping assembly for BNCT. Appl Radiat Isot 2022; 190:110465. [DOI: 10.1016/j.apradiso.2022.110465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Revised: 08/31/2022] [Accepted: 09/13/2022] [Indexed: 11/02/2022]
|
11
|
Wada S, Komori T, de Jesus CS, Nomura T, Komura T, Yonekura S, Shibuya R, Adachi E, Sakurai Y, Ishikawa M, Usui S, Kambe N, Kabashima K. Anti-BP180, pruritus, and thymus and activation-regulated chemokines as surrogate markers for disease activity in bullous pemphigoid. J Eur Acad Dermatol Venereol 2022; 36:e1061-e1063. [PMID: 35857404 DOI: 10.1111/jdv.18449] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- S Wada
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - T Komori
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - C S de Jesus
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - T Nomura
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.,Department of Drug Discovery for Intractable Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - T Komura
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - S Yonekura
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - R Shibuya
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - E Adachi
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Y Sakurai
- Department of Dermatology, Saiseikai Noe Hospital, Osaka, Japan
| | - M Ishikawa
- Department of Dermatology, Kyoto Katsura Hospital, Kyoto, Japan
| | - S Usui
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - N Kambe
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - K Kabashima
- Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
| |
Collapse
|
12
|
Koyama M, Ishikawa M, Tajima K. Current status of countermeasures for ageing of nuclear power plants in Japan. KERNTECHNIK 2022. [DOI: 10.1515/kern-2002-0073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
This paper summarizes ageing countermeasure program of the nuclear power plants performed by the Japanese Government and industries and related activities, and describes current research program and utilization of the research results for the aged nuclear power plants. Regulatory bodies (NISA of METI: Nuclear and Industrial Safety Agency of the Ministry of Economy, Trade and Industry') reviewed the ageing issues of nuclear power plants to enhance countermeasures for the aged plants. Nuclear Power Plant Life Engineering Center (PLEC) entrusted by NISA is carrying out the task relating to the aged plants.
Collapse
Affiliation(s)
- M. Koyama
- Nuclear Power Plant Life Engineering Center (PLEC), Japan Power Plant Life Engineering and Inspection Corporation (JAPEIC) , 5-11, Akasaka 1-chome, Minato-ku. Tokyo , 107-0052 Japan
| | - M. Ishikawa
- Nuclear Power Plant Life Engineering Center (PLEC), Japan Power Plant Life Engineering and Inspection Corporation (JAPEIC) , 5-11, Akasaka 1-chome, Minato-ku. Tokyo , 107-0052 Japan
| | - K. Tajima
- Nuclear Power Plant Life Engineering Center (PLEC), Japan Power Plant Life Engineering and Inspection Corporation (JAPEIC) , 5-11, Akasaka 1-chome, Minato-ku. Tokyo , 107-0052 Japan
| |
Collapse
|
13
|
Matsuya Y, Hamada N, Yachi Y, Satou Y, Ishikawa M, Date H, Sato T. Inflammatory Signaling and DNA Damage Responses after Local Exposure to an Insoluble Radioactive Microparticle. Cancers (Basel) 2022; 14:cancers14041045. [PMID: 35205797 PMCID: PMC8869995 DOI: 10.3390/cancers14041045] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2022] [Revised: 02/09/2022] [Accepted: 02/15/2022] [Indexed: 12/30/2022] Open
Abstract
Simple Summary A cesium-bearing microparticle (Cs-BMP) is an insoluble radioactive microparticle possessing high specific radioactivity, which was discovered after the incident at the Fukushima nuclear power plant. Due to their insoluble nature, such Cs-BMPs are assumed to adhere in the long term to normal tissue, leading to chronic local exposure. However, radiation risk due to the intake of internal exposure to radioactive cesium is conventionally estimated from the organ dose given by uniform exposure to soluble cesium. As such, it is critical to clarify the normal tissue effects posed by heterogeneous exposure to Cs-BMPs. This in vitro study reports on the relationship between the inflammatory responses and DNA damage induction during local exposure to a Cs-BMP. Abstract Cesium-bearing microparticles (Cs-BMPs) can reach the human respiratory system after inhalation, resulting in chronic local internal exposure. We previously investigated the spatial distribution of DNA damage induced in areas around a Cs-BMP; however, the biological impacts have not been fully clarified due to the limited amount of data. Here, we investigated the inflammatory signaling and DNA damage responses after local exposure to a Cs-BMP in vitro. We used two normal human lung cell lines, i.e., lung fibroblast cells (WI-38) and bronchial epithelial cells (HBEC3-KT). After 24 h exposure to a Cs-BMP, inflammation was evaluated by immunofluorescent staining for nuclear factor κB (NF-κB) p65 and cyclooxygenase 2 (COX-2). The number of DNA double-strand breaks (DSBs) was also detected by means of phospholylated histone H2AX (γ-H2AX) focus formation assay. Cs-BMP exposure significantly increased NF-κB p65 and COX-2 expressions, which were related to the number of γ-H2AX foci in the cell nuclei. Compared to the uniform (external) exposure to 137Cs γ-rays, NF-κB tended to be more activated in the cells proximal to the Cs-BMP, while both NF-κB p65 and COX-2 were significantly activated in the distal cells. Experiments with chemical inhibitors for NF-κB p65 and COX-2 suggested the involvement of such inflammatory responses both in the reduced radiosensitivity of the cells proximal to Cs-BMP and the enhanced radiosensitivity of the cells distal from Cs-BMP. The data show that local exposure to Cs-BMP leads to biological effects modified by the NF-κB pathway, suggesting that the radiation risk for Cs-BMP exposure can differ from that estimated based on conventional uniform exposure to normal tissues.
Collapse
Affiliation(s)
- Yusuke Matsuya
- Nuclear Science and Engineering Center, Japan Atomic Energy Agency (JAEA), 2-4 Shirakata, Tokai 319-1195, Ibaraki, Japan;
- Correspondence:
| | - Nobuyuki Hamada
- Radiation Safety Unit, Biology and Environmental Chemistry Division, Sustainable System Research Laboratory, Central Research Institute of Electric Power Industry (CRIEPI), 2-11-1 Iwado-kita, Komae 201-8511, Tokyo, Japan;
| | - Yoshie Yachi
- Graduate School of Health Sciences, Hokkaido University, Kita-12 Nishi-8, Kita-ku, Sapporo 060-0812, Hokkaido, Japan;
| | - Yukihiko Satou
- Collaborative Laboratories for Advanced Decommissioning Science (CLADS), Japan Atomic Energy Agency (JAEA), 790-1 Otsuka, Motooka Tomioka, Futaba 979-1151, Fukushima, Japan;
| | - Masayori Ishikawa
- Faculty of Health Sciences, Hokkaido University, Kita-12 Nishi-8, Kita-ku, Sapporo 060-0812, Hokkaido, Japan; (M.I.); (H.D.)
| | - Hiroyuki Date
- Faculty of Health Sciences, Hokkaido University, Kita-12 Nishi-8, Kita-ku, Sapporo 060-0812, Hokkaido, Japan; (M.I.); (H.D.)
| | - Tatsuhiko Sato
- Nuclear Science and Engineering Center, Japan Atomic Energy Agency (JAEA), 2-4 Shirakata, Tokai 319-1195, Ibaraki, Japan;
| |
Collapse
|
14
|
Abstract
Abstract
Background
There is abundant evidence linking long working hours among physicians with adverse health effects; however, most studies have focused on medical residents. In Japan, obstetrician/gynaecologists (OB/GYNs) work the longest hours, yet no studies have investigated potential relationships between excessive overtime and depression and suicidal ideation within this population.
Aims
To investigate the relationship between long working hours and depression and suicidal ideation among OB/GYNs in Japan.
Methods
We administered a survey questionnaire to OB/GYNs and received 919 valid responses. Multivariate logistic regression was performed with depression and suicidal ideation as the outcome variables and number of working hours per week, gender, age, marital status, hospital type and geographical area type as the explanatory variables.
Results
Sixteen per cent of the participants were depressed, and 3% reported suicidal ideation. Working 100 or more hours per week increased the odds for both depression and suicidal ideation [odds ratio (OR): 2.08 (95% confidence interval {CI}: 1.07–4.05, P = 0.03); and OR: 7.03 (95% CI: 1.95–25.38, P < 0.001), respectively].
Conclusions
The results suggest that the Japanese Government should vigorously promote physicians’ work-style reform, so that a lowered upper limit of overtime hours will be enforced from 2024 to improve physicians’ health and patients’ safety.
Collapse
Affiliation(s)
- M Ishikawa
- Department of Health Services Research, Faculty of Medicine, University of Tsukuba, 1-1-1 Tenno-dai, Tsukuba, Ibaraki 305-8575, Japan
| |
Collapse
|
15
|
Ishikawa M, Yamamoto T. Plaque psoriasis in a patient with sarcoidosis. Actas Dermo-Sifiliográficas (English Edition) 2021. [DOI: 10.1016/j.adengl.2021.07.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
16
|
Ishikawa M, Yamamoto T. Psoriasis en placa en un paciente con sarcoidosis. Actas Dermo-Sifiliográficas 2021. [DOI: 10.1016/j.ad.2020.02.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
17
|
Ukon K, Arai Y, Takao S, Matsuura T, Ishikawa M, Shirato H, Shimizu S, Umegaki K, Miyamoto N. Prediction of target position from multiple fiducial markers by partial least squares regression in real-time tumor-tracking radiation therapy. J Radiat Res 2021; 62:926-933. [PMID: 34196697 PMCID: PMC8438269 DOI: 10.1093/jrr/rrab054] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/19/2021] [Revised: 03/24/2021] [Indexed: 06/13/2023]
Abstract
The purpose of this work is to show the usefulness of a prediction method of tumor location based on partial least squares regression (PLSR) using multiple fiducial markers. The trajectory data of respiratory motion of four internal fiducial markers inserted in lungs were used for the analysis. The position of one of the four markers was assumed to be the tumor position and was predicted by other three fiducial markers. Regression coefficients for prediction of the position of the tumor-assumed marker from the fiducial markers' positions is derived by PLSR. The tracking error and the gating error were evaluated assuming two possible variations. First, the variation of the position definition of the tumor and the markers on treatment planning computed tomograhy (CT) images. Second, the intra-fractional anatomical variation which leads the distance change between the tumor and markers during the course of treatment. For comparison, rigid predictions and ordinally multiple linear regression (MLR) predictions were also evaluated. The tracking and gating errors of PLSR prediction were smaller than those of other prediction methods. Ninety-fifth percentile of tracking/gating error in all trials were 3.7/4.1 mm, respectively in PLSR prediction for superior-inferior direction. The results suggested that PLSR prediction was robust to variations, and clinically applicable accuracy could be achievable for targeting tumors.
Collapse
Affiliation(s)
- Kanako Ukon
- Graduate School of Medicine, Hokkaido University, North 15, West 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan
| | - Yohei Arai
- Graduate School of Engineering, Hokkaido University, North 13, West 8, Kita-ku, Sapporo, Hokkaido 060-8628, Japan
| | - Seishin Takao
- Department of Medical Physics, Hokkaido University Hospital, North 14, West 5, Kita-ku, Sapporo, Hokkaido 060-8648, Japan
- Faculty of Engineering, Hokkaido University, North13, West 8, Kita-ku, Sapporo, Hokkaido 060-8628, Japan
| | - Taeko Matsuura
- Department of Medical Physics, Hokkaido University Hospital, North 14, West 5, Kita-ku, Sapporo, Hokkaido 060-8648, Japan
- Faculty of Engineering, Hokkaido University, North13, West 8, Kita-ku, Sapporo, Hokkaido 060-8628, Japan
| | - Masayori Ishikawa
- Faculty of Health Sciences, Hokkaido University, North12, West 5, Kita-ku, Sapporo, Hokkaido 060-0812, Japan
| | - Hiroki Shirato
- Faculty of Medicine, Hokkaido University, North 15, West 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan
| | - Shinichi Shimizu
- Department of Medical Physics, Hokkaido University Hospital, North 14, West 5, Kita-ku, Sapporo, Hokkaido 060-8648, Japan
- Faculty of Medicine, Hokkaido University, North 15, West 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan
| | - Kikuo Umegaki
- Faculty of Engineering, Hokkaido University, North13, West 8, Kita-ku, Sapporo, Hokkaido 060-8628, Japan
| | - Naoki Miyamoto
- Corresponding author: Faculty of Engineering, Hokkaido University, North 13, West 8, Kita-ku, Sapporo, Hokkaido 060-8638, Japan. Tel: +81-11-706-6673, E-mail address:
| |
Collapse
|
18
|
Nishio S, Matsuo K, Nasu H, Murotani K, Mikami Y, Yaegashi N, Satoh T, Okamoto A, Ishikawa M, Miyamoto T, Mandai M, Takehara K, Yahata H, Takekuma M, Ushijima K. 792P Analysis of postoperative adjuvant chemotherapy in 102 patients with gastric-type mucinous carcinoma of the uterine cervix: A multi-institutional study. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
19
|
Kry S, Lye J, Clark C, Andratschke N, Dimitriadis A, Followill D, Howell R, Hussein M, Ishikawa M, Kito S, Kron T, Lee J, Michalski J, Monti A, Reynaert N, Taylor P, Venables K, Xiao Y, Lehmann J. PD-0899 Report dose-to-medium in clinical trials; a consensus from the Global Harmonisation Group. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07178-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
20
|
Kanou H, Nagasawa K, Ishii Y, Chishima A, Hayashi J, Haga S, Sutherland K, Ishikawa M, Ozaki M, Shirato H, Hamada K, Hamada T. Period1 gene expression in the olfactory bulb and liver of freely moving streptozotocin-treated diabetic mouse. Biochem Biophys Res Commun 2021; 560:14-20. [PMID: 33965785 DOI: 10.1016/j.bbrc.2021.04.049] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2021] [Accepted: 04/14/2021] [Indexed: 10/21/2022]
Abstract
Clock genes express circadian rhythms in most organs. These rhythms are organized throughout the whole body, regulated by the suprachiasmatic nucleus (SCN) in the brain. Disturbance of these clock gene expression rhythms is a risk factor for diseases such as obesity. In the present study, to explore the role of clock genes in developing diabetes, we examined the effect of streptozotocin (STZ)-induced high glucose on Period1 (Per1) gene expression rhythm in the liver and the olfactory bub (OB) in the brain. We found a drastic increase of Per1 expression in both tissues after STZ injection while blood glucose content was low. After a rapid expression peak, Per1 expression showed no rhythm. Associated with an increase of glucose content, behavior became arrhythmic. Finally, we succeeded in detecting an increase of Per1 expression in mice hair follicles on day 1 after STZ administration, before the onset of symptoms. These results show that elevated Per1 expression by STZ plays an important role in the aggravation of diabetes.
Collapse
Affiliation(s)
- Harumi Kanou
- Department of Pharmaceutical Sciences, International University of Health and Welfare, Ohtawara, Tochigi, 324-8501, Japan
| | - Kouki Nagasawa
- Department of Pharmaceutical Sciences, International University of Health and Welfare, Ohtawara, Tochigi, 324-8501, Japan
| | - Yuki Ishii
- Department of Pharmaceutical Sciences, International University of Health and Welfare, Ohtawara, Tochigi, 324-8501, Japan
| | - Aya Chishima
- Department of Pharmaceutical Sciences, International University of Health and Welfare, Ohtawara, Tochigi, 324-8501, Japan
| | - Juri Hayashi
- Department of Pharmaceutical Sciences, International University of Health and Welfare, Ohtawara, Tochigi, 324-8501, Japan
| | - Sanae Haga
- Laboratory of Molecular and Functional Bioimaging, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan
| | - Kenneth Sutherland
- Global Center for Biomedical Science and Engineering, Hokkaido University, Sapporo, Hokkaido, 060-8012, Japan
| | - Masayori Ishikawa
- Global Center for Biomedical Science and Engineering, Hokkaido University, Sapporo, Hokkaido, 060-8012, Japan; Graduate School of Health Sciences, Hokkaido University. Sapporo, Hokkaido, 060-8638, Japan
| | - Michitaka Ozaki
- Laboratory of Molecular and Functional Bioimaging, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan; Department of Biological Response and Regulation, Faculty of Health Sciences, Hokkaido University, Sapporo, Hokkaido, 060-0812, Japan
| | - Hiroki Shirato
- Global Center for Biomedical Science and Engineering, Hokkaido University, Sapporo, Hokkaido, 060-8012, Japan; Hokkaido University Hospital, Sapporo, Hokkaido, 060-8638, Japan
| | - Kazuko Hamada
- Department of Pharmaceutical Sciences, International University of Health and Welfare, Ohtawara, Tochigi, 324-8501, Japan
| | - Toshiyuki Hamada
- Department of Pharmaceutical Sciences, International University of Health and Welfare, Ohtawara, Tochigi, 324-8501, Japan; Department of Biological Response and Regulation, Faculty of Health Sciences, Hokkaido University, Sapporo, Hokkaido, 060-0812, Japan; Hakujikai Institute of Gerontology, 5-11-1, Shikahama, Adachi Ward, Tokyo, 123-0864, Japan.
| |
Collapse
|
21
|
Igari S, Ito T, Ishikawa M, Hiraiwa T, Yamamoto T. Secondary Amyloid Deposition in Pigmented Poroma. Actas Dermosifiliogr (Engl Ed) 2021; 112:S1578-2190(21)00187-6. [PMID: 34147678 DOI: 10.1016/j.adengl.2021.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- S Igari
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan
| | - T Ito
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan
| | - M Ishikawa
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan
| | - T Hiraiwa
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan
| | - T Yamamoto
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
| |
Collapse
|
22
|
Kimura S, Miyamoto N, Sutherland KL, Suzuki R, Shirato H, Ishikawa M. Fundamental study on quality assurance (QA) procedures for a real-time tumor tracking radiotherapy (RTRT) system from the viewpoint of imaging devices. J Appl Clin Med Phys 2021; 22:165-176. [PMID: 34080303 PMCID: PMC8292702 DOI: 10.1002/acm2.13307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2021] [Revised: 04/25/2021] [Accepted: 05/12/2021] [Indexed: 11/10/2022] Open
Abstract
PURPOSE The real-time tumor tracking radiotherapy (RTRT) system requires periodic quality assurance (QA) and quality control. The goal of this study is to propose QA procedures from the viewpoint of imaging devices in the RTRT system. METHODS Tracking by the RTRT system (equips two sets of colored image intensifiers (colored I.I.s) fluoroscopy units) for the moving gold-marker (diameter 2.0 mm) in a rotating phantom were performed under various X-ray conditions. To analyze the relationship between fluoroscopic image quality and precision of gold marker coordinate calculation, the standard deviation of the 3D coordinate (σ3D [mm]) of the gold marker, the mean of the pattern recognition score (PRS) and the standard deviation of the distance between rays (DBR) (σDBR [mm]) were evaluated. RESULTS When tracking with speed of 10-60 mm/s, σDBR increased, though the mean PRS did not change significantly (p>0.05). On the contrary, the mean PRS increased depending on the integral noise equivalent quanta (∫NEQ) that is an indicator of image quality calculated from the modulation transfer function (MTF) as an indicator of spatial resolution and the noise power spectrum (NPS) as an indicator of noise characteristic. CONCLUSION The indicators of NEQ, MTF, and NPS were useful for managing the tracking accuracy of the RTRT system. We propose observing the change of these indicators as additional QA procedures for each imaging device from the commissioning baseline.
Collapse
Affiliation(s)
- Suguru Kimura
- Department of Medical Physics, Graduate school of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.,Division of Radiological Technology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan
| | - Naoki Miyamoto
- Faculty of Engineering, Hokkaido University, Sapporo, Hokkaido, Japan
| | - Kenneth L Sutherland
- Global Center for Biomedical Science and Engineering, Faculty of Medicine, Sapporo, Hokkaido, Japan
| | - Ryusuke Suzuki
- Department of Medical Physics, Hokkaido University Hospital, Sapporo, Hokkaido, Japan
| | - Hiroki Shirato
- Global Center for Biomedical Science and Engineering, Faculty of Medicine, Sapporo, Hokkaido, Japan
| | - Masayori Ishikawa
- Department of biomedical science and Engineering, Faculty of Health science, Hokkaido University, Sapporo, Hokkaido, Japan
| |
Collapse
|
23
|
Igari S, Ito T, Ishikawa M, Hiraiwa T, Yamamoto T. Secondary Amyloid Deposition in Pigmented Poroma. Actas Dermosifiliogr (Engl Ed) 2021; 112:S0001-7310(21)00172-1. [PMID: 33964220 DOI: 10.1016/j.ad.2020.01.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2019] [Revised: 12/20/2019] [Accepted: 01/26/2020] [Indexed: 11/16/2022] Open
Affiliation(s)
- S Igari
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan
| | - T Ito
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan
| | - M Ishikawa
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan
| | - T Hiraiwa
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan
| | - T Yamamoto
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
| |
Collapse
|
24
|
Matsuya Y, McMahon SJ, Butterworth KT, Naijo S, Nara I, Yachi Y, Saga R, Ishikawa M, Sato T, Date H, Prise KM. Oxygen enhancement ratios of cancer cells after exposure to intensity modulated x-ray fields: DNA damage and cell survival. Phys Med Biol 2021; 66. [PMID: 33735839 DOI: 10.1088/1361-6560/abf011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2020] [Accepted: 03/18/2021] [Indexed: 11/12/2022]
Abstract
Hypoxic cancer cells within solid tumours show radio-resistance, leading to malignant progression in fractionated radiotherapy. When prescribing dose to tumours under heterogeneous oxygen pressure with intensity-modulated radiation fields, intercellular signalling could have an impact on radiosensitivity between in-field and out-of-field (OF) cells. However, the impact of hypoxia on radio-sensitivity under modulated radiation intensity remains to be fully clarified. Here, we investigate the impact of hypoxia on in-field and OF radio-sensitivities using two types of cancer cells, DU145 and H1299. Using a nBIONIX hypoxic culture kit and a shielding technique to irradiate 50% of a cell culture flask, oxygen enhancement ratios for double-strand breaks (DSB) and cell death endpoints were determined. Thesein vitromeasurements indicate that hypoxia impacts OF cells, although the hypoxic impacts on OF cells for cell survival were dose-dependent and smaller compared to those for in-field and uniformly irradiated cells. These decreased radio-sensitivities of OF cells were shown as a consistent tendency for both DSB and cell death endpoints, suggesting that radiation-induced intercellular communication is of importance in advanced radiotherapy dose-distributions such as with intensity-modulated radiotherapy.
Collapse
Affiliation(s)
- Yusuke Matsuya
- Nuclear Science and Engineering Center, Research Group for Radiation Transport Analysis, Japan Atomic Energy Agency (JAEA), 2-4 Shirakata, Tokai, Ibaraki, 319-1195, Japan.,Faculty of Health Sciences, Hokkaido University, Kita-12 Nishi-5, Kita-ku, Sapporo, Hokkaido, 060-0812, Japan
| | - Stephen J McMahon
- Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, 97 Lisburn Road, BT7 9AE, Belfast, United Kingdom
| | - Karl T Butterworth
- Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, 97 Lisburn Road, BT7 9AE, Belfast, United Kingdom
| | - Shingo Naijo
- Graduate School of Health Sciences, Hokkaido University, Kita-12 Nishi-5, Kita-ku, Sapporo, Hokkaido, 060-0812, Japan.,Department of Radiology, Tokyo University Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
| | - Isshi Nara
- Graduate School of Biomedical Science and Engineering, Hokkaido University, Kita-15 Nishi-7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan
| | - Yoshie Yachi
- Graduate School of Health Sciences, Hokkaido University, Kita-12 Nishi-5, Kita-ku, Sapporo, Hokkaido, 060-0812, Japan
| | - Ryo Saga
- Graduate School of Health Sciences, Hirosaki University, 66-1 Hon-cho, Hirosaki, 036-8564, Japan
| | - Masayori Ishikawa
- Faculty of Health Sciences, Hokkaido University, Kita-12 Nishi-5, Kita-ku, Sapporo, Hokkaido, 060-0812, Japan
| | - Tatsuhiko Sato
- Nuclear Science and Engineering Center, Research Group for Radiation Transport Analysis, Japan Atomic Energy Agency (JAEA), 2-4 Shirakata, Tokai, Ibaraki, 319-1195, Japan
| | - Hiroyuki Date
- Faculty of Health Sciences, Hokkaido University, Kita-12 Nishi-5, Kita-ku, Sapporo, Hokkaido, 060-0812, Japan
| | - Kevin M Prise
- Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, 97 Lisburn Road, BT7 9AE, Belfast, United Kingdom
| |
Collapse
|
25
|
Yamada S, Ito H, Ishikawa M, Yamamoto K, Yamaguchi M, Oshima M, Nozaki K. Quantification of Oscillatory Shear Stress from Reciprocating CSF Motion on 4D Flow Imaging. AJNR Am J Neuroradiol 2021; 42:479-486. [PMID: 33478942 DOI: 10.3174/ajnr.a6941] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2020] [Accepted: 10/05/2020] [Indexed: 01/18/2023]
Abstract
BACKGROUND AND PURPOSE Oscillatory shear stress could not be directly measured in consideration of direction, although cerebrospinal fluid has repetitive movements synchronized with heartbeat. Our aim was to evaluate the important of oscillatory shear stress in the cerebral aqueduct and foramen magnum in idiopathic normal pressure hydrocephalus by comparing it with wall shear stress and the oscillatory shear index in patients with idiopathic normal pressure hydrocephalus. MATERIALS AND METHODS By means of the 4D flow application, oscillatory shear stress, wall shear stress, and the oscillatory shear index were measured in 41 patients with idiopathic normal pressure hydrocephalus, 23 with co-occurrence of idiopathic normal pressure hydrocephalus and Alzheimer-type dementia, and 9 age-matched controls. These shear stress parameters at the cerebral aqueduct were compared with apertures and stroke volumes at the foramen of Magendie and cerebral aqueduct. RESULTS Two wall shear stress magnitude peaks during a heartbeat were changed to periodic oscillation by converting oscillatory shear stress. The mean oscillatory shear stress amplitude and time-averaged wall shear stress values at the dorsal and ventral regions of the cerebral aqueduct in the idiopathic normal pressure hydrocephalus groups were significantly higher than those in controls. Furthermore, those at the ventral region of the cerebral aqueduct in the idiopathic normal pressure hydrocephalus group were also significantly higher than those in the co-occurrence of idiopathic normal pressure hydrocephalus with Alzheimer-type dementia group. The oscillatory shear stress amplitude at the dorsal region of the cerebral aqueduct was significantly associated with foramen of Magendie diameters, whereas it was strongly associated with the stroke volume at the upper end of the cerebral aqueduct rather than that at the foramen of Magendie. CONCLUSIONS Oscillatory shear stress, which reflects wall shear stress vector changes better than the conventional wall shear stress magnitude and the oscillatory shear index, can be directly measured on 4D flow MR imaging. Oscillatory shear stress at the cerebral aqueduct was considerably higher in patients with idiopathic normal pressure hydrocephalus.
Collapse
Affiliation(s)
- S Yamada
- From the Department of Neurosurgery (S.Y., K.N.), Shiga University of Medical Science, Shiga, Japan .,Department of Neurosurgery and Normal Pressure Hydrocephalus Center (S.Y., K.Y., M.Y.), Rakuwakai Otowa Hospital, Kyoto, Japan.,Interfaculty Initiative in Information Studies/Institute of Industrial Science (S.Y., M.O.), The University of Tokyo, Tokyo, Japan
| | - H Ito
- Medical System Research and Development Center (H.I.), Fujifilm Corporation, Tokyo, Japan
| | | | - K Yamamoto
- Department of Neurosurgery and Normal Pressure Hydrocephalus Center (S.Y., K.Y., M.Y.), Rakuwakai Otowa Hospital, Kyoto, Japan
| | - M Yamaguchi
- Department of Neurosurgery and Normal Pressure Hydrocephalus Center (S.Y., K.Y., M.Y.), Rakuwakai Otowa Hospital, Kyoto, Japan
| | - M Oshima
- Interfaculty Initiative in Information Studies/Institute of Industrial Science (S.Y., M.O.), The University of Tokyo, Tokyo, Japan
| | - K Nozaki
- From the Department of Neurosurgery (S.Y., K.N.), Shiga University of Medical Science, Shiga, Japan
| |
Collapse
|
26
|
Nishio T, Nakamura M, Okamoto H, Kito S, Minemura T, Ozawa S, Kumazaki Y, Ishikawa M, Tohyama N, Kurooka M, Nakashima T, Shimizu H, Suzuki R, Ishikura S, Nishimura Y. An overview of the medical-physics-related verification system for radiotherapy multicenter clinical trials by the Medical Physics Working Group in the Japan Clinical Oncology Group-Radiation Therapy Study Group. J Radiat Res 2020; 61:999-1008. [PMID: 32989445 PMCID: PMC7674673 DOI: 10.1093/jrr/rraa089] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Revised: 08/25/2020] [Indexed: 05/14/2023]
Abstract
The Japan Clinical Oncology Group-Radiation Therapy Study Group (JCOG-RTSG) has initiated several multicenter clinical trials for high-precision radiotherapy, which are presently ongoing. When conducting multi-center clinical trials, a large difference in physical quantities, such as the absolute doses to the target and the organ at risk, as well as the irradiation localization accuracy, affects the treatment outcome. Therefore, the differences in the various physical quantities used in different institutions must be within an acceptable range for conducting multicenter clinical trials, and this must be verified with medical physics consideration. In 2011, Japan's first Medical Physics Working Group (MPWG) in the JCOG-RTSG was established to perform this medical-physics-related verification for multicenter clinical trials. We have developed an auditing method to verify the accuracy of the absolute dose and the irradiation localization. Subsequently, we credentialed the participating institutions in the JCOG multicenter clinical trials that were using stereotactic body radiotherapy (SBRT) for lungs, intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) for several disease sites, and proton beam therapy (PT) for the liver. From the verification results, accuracies of the absolute dose and the irradiation localization among the participating institutions of the multicenter clinical trial were assured, and the JCOG clinical trials could be initiated.
Collapse
Affiliation(s)
- Teiji Nishio
- Corresponding author. Department of Medical Physics, Graduate School of Medicine, Tokyo Women’s Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. Tel: +81-3-3353-8111; Fax: +81-3-5269-7040;
| | - Mitsuhiro Nakamura
- Division of Medical Physics, Department of Information Technology and Medical Engineering, Human He Sciences, Graduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan
- Medical Physics Working Group (MPWG) in Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Hiroyuki Okamoto
- Department of Medical Physics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan
- Medical Physics Working Group (MPWG) in Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Satoshi Kito
- Department of Radiology, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Sumida-ku, Tokyo 130-8575, Japan
- Department of Radiation Oncology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan
- Division of Medical Physics, Department of Information Technology and Medical Engineering, Human He Sciences, Graduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan
- Medical Physics Working Group (MPWG) in Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Toshiyuki Minemura
- Division of Medical Support and Partnership, Center for Cancer Control and Information Services, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
- Medical Physics Working Group (MPWG) in Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Shuichi Ozawa
- Department of Radiation Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan
- Hiroshima High-Precision Radiotherapy Cancer Center, 3-2-2, Futabanosato, Higashi-ku, Hiroshima 732-0057, Japan
- Medical Physics Working Group (MPWG) in Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Yu Kumazaki
- Department of Radiation Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama 350-1298, Japan
- Medical Physics Working Group (MPWG) in Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Masayori Ishikawa
- Faculty of Health Sciences, Hokkaido University, N-12 W-5 Kita-ku, Sapporo, 060-0812, Japan
- Medical Physics Working Group (MPWG) in Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Naoki Tohyama
- Division of Medical Physics, Tokyo Bay Advanced Imaging & Radiation Oncology Makuhari Clinic, 1-17 Toyosuna, Mihama-ku, Chiba, 261-0024, Japan
- Medical Physics Working Group (MPWG) in Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Masahiko Kurooka
- Department of Radiation Therapy, Tokyo Medical University Hospital, 6-7-1, Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
- Medical Physics Working Group (MPWG) in Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Takeo Nakashima
- Radiation Therapy Section, Department of Clinical Support, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan
- Medical Physics Working Group (MPWG) in Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Hidetoshi Shimizu
- Department of Radiation Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, Japan
- Medical Physics Working Group (MPWG) in Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Ryusuke Suzuki
- Department of Medical Physics, Hokkaido University Hospital, North-14, West-5, Kita-Ku, Sapporo, Hokkaido 060-8638, Japan
- Medical Physics Working Group (MPWG) in Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Satoshi Ishikura
- Department of Radiology, Graduate School of Medical Sciences, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan
- Radiotherapy Committee (RC) in Japan Clinical Oncology Group, Tokyo, Japan
- Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| | - Yasumasa Nishimura
- Department of Radiation Oncology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan
- Japan Clinical Oncology Group - Radiation Therapy Study Group (JCOG-RTSG), Tokyo, Japan
| |
Collapse
|
27
|
Watanabe T, Abe K, Ishikawa M, Ishikawa T, Imakiire S, Ohtsubo T, Kaneko K, Fukuuchi T, Tsutsui H. Hyperuricemia impaired nitric oxide bioavailablity and deteriorated pulmonary arterial hypertension via a uric acid transporter, URATv1 in xanthine oxidoreductase (XOR)-independent manner. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Hyperuricemia occurs in approximately 80% in patients with pulmonary arterial hypertension (PAH) and is positively correlated with pulmonary arterial pressure (PAP). It has been reported that uric acid (UA) reduced endothelium derived nitric oxide (NO) production in porcine pulmonary arterial endothelial cells (PAEC). However, the effects of UA and xanthine oxidoreductase (XOR), catalytic enzyme of UA, on the development of PAH have not been fully elucidated.
Purpose
We examined the followings; (1) the effects of hyperuricemia on the endothelial function and the development of PAH in rats (2) the therapeutic effects of UA transporter inhibitor on PAH in rats, and (3) the role of XOR in PAH in mice.
Methods
We used normal and 5-wk Sugen5416/Hypoxia/Normoxia-exposed (SU/Hx/Nx) rats. Gene expression levels of URATv1, a UA transporter, were measured by RT-PCR. We determined the isometric tension of PA rings isolated from normal rats. The study with the isolated perfused lung preparation was performed in SU/HX/Nx rats. To investigate the chronic effect of UA on the development of PAH, hyperuricemia was induced by the administration of 2% oxonic acid (OA) in diet for 6-wk. Benzbromarone (BBR, 10mg/kg/day, diet, from weeks 0 to 5), a URATv1 transporter inhibitor, was administered in the SU/Hx/Nx-rats with or without 2%OA. To examine the role of XOR in PAH, XOR+/− and wild type (WT) mice were exposed to 3-wk Nx or Hx (10% O2).
Results
The mRNA of URATv1 was detected in the normal lungs. Isometric tension study showed that UA (8 mg/dl) inhibited acetylcholine-induced vasorelaxation. In perfused lung preparations, UA acutely increased estimated PVR in a dose-dependent manner (1.6–16.0mg/dl) with reducing cGMP levels in the lungs. BBR significantly attenuated the pressor response to UA. UA levels in the plasma and the lung tissues were significantly elevated in SU/Hx/Nx-rats with 2%OA (normal vs. vehicle vs. 2%OA, plasma: 0.24±0.01 vs. 0.80±0.14 and 1.44±0.17 mg/dl; lung tissues: 68±3 vs. 142±3 and 377±46 pmol/g tissue). They exhibited further elevation of right ventricle systolic pressure (RVSP) (31±2 vs. 72±6 vs. 101±3 mmHg) and Ea (a marker of RV afterload) (0.24±0.04 vs. 0.97±0.15 vs. 2.36±0.49 mmHg/μL) with the exacerbation of occlusive lesions of PAs. BBR had no changes in the UA levels in the plasma (1.93±0.30 mg/dL), but significantly reduced the UA levels in the lung tissues (101±10 pmol/g tissue) and attenuated the increase in RVSP (53±8mmHg) and Ea (0.21±0.05 mmHg/mL) in the SU/Hx/Nx-rats with 2%OA. On the other hand, BBR had no effects on RVSP (76±7 mmHg) and Ea (0.91±0.15 mmHg/mL) in the SU/Hx/Nx-rats without 2%OA. There were no significant differences in RVSP between XOR+/− mice with Hx and WT with Hx (26±2 vs. 26±2 mmHg).
Conclusions
Hyperuricemia itself impairs endothelial function and deteriorates PAH via URATv1 in a XOR-independent manner. UA can be a novel therapeutic target for PAH.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- T Watanabe
- Kyushu University Hospital, Fukuoka, Japan
| | - K Abe
- Kyushu University Hospital, Fukuoka, Japan
| | - M Ishikawa
- Fukuoka Children's Hospital, Fukuoka, Japan
| | - T Ishikawa
- Kyushu University Hospital, Fukuoka, Japan
| | - S Imakiire
- Kyushu University Hospital, Fukuoka, Japan
| | - T Ohtsubo
- Fukuoka Red Cross Hospital, Fukuoka, Japan
| | - K Kaneko
- Teikyo University, Faculty of Pharma-Science, Tokyo, Japan
| | - T Fukuuchi
- Teikyo University, Faculty of Pharma-Science, Tokyo, Japan
| | - H Tsutsui
- Kyushu University Hospital, Fukuoka, Japan
| |
Collapse
|
28
|
Muramatsu T, Ishikawa M, Nanasato M, Nagasaka R, Takatsu H, Yoshiki Y, Hashimoto Y, Ohota M, Kamiya H, Yoshida Y, Murohara T, Ozaki Y, Izawa H. Comparison between optical frequency domain imaging and intravascular ultrasound in PCI guidance for Biolimus A9 eluting stent implantation. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
It has been reported that intravascular ultrasound (IVUS) guided PCI reduced a risk of major adverse cardiac event compared to conventional angiography guided PCI, while comparison between IVUS-guided and optical frequency domain imaging (OFDI)-guided PCI specifically in long-term clinical outcomes (>1 year) has been unexplored.
Purpose
We sought to compare imaging surrogates at 8 months and clinical outcomes beyond 1 year after drug-eluting stent implantation between IVUS and OFDI guidance.
Methods
The MISTIC-1 is a prospective, multi-centre, single-blinded, randomised-controlled, non-inferiority trial comparing OFDI-guided and IVUS-guided PCI using Biolimus A9 eluting Nobori stent. We enrolled patients with stable coronary artery disease who have symptoms or clinically relevant myocardial ischemia. Stent landing zones were selected in the most normal looking sites with largest lumen and without percentage plaque area >50% in IVUS group while without lipidic plaque of >2 quadrants or suggestive thin-cap fibroatheroma in OFDI group. Stent sizing was based on external elastic lamina (EEL) in IVUS group, while by taking 10% or 0.25mm larger than mean lumen diameter at reference sites in OFDI group. Stent optimisation with in-stent minimum lumen area ≥80% of the average lumen area at proximal and distal reference sites was encouraged in both groups. Primary efficacy endpoint is in-segment minimum lumen area (MLA) assessed by OFDI at 8 months. Secondary safety endpoint is a composite of cardiovascular death, target vessel myocardial infarction, or target lesion revascularisation. Based on the assumption that mean in-segment MLA at follow-up was 4.5mm2 with a standard deviation of 2.0mm2 in the control (IVUS) group and a non-inferiority limit of 1.2mm2 for OFDI group, sample size was estimated as 48 cases in each group with 5% type I error and 90% statistical power.
Results
Since June-2014 and August-2016, we prospectively enrolled 109 patients (mean age 70 years, male 78%) with 126 lesions. Baseline patient and lesion characteristics were well balanced and average nominal size and length of stent used did not differ between OFDI-guided and IVUS-guided PCI (3.0 and 19.1mm vs. 3.1 and 19.3mm, respectively). Post-procedural minimum stent area was 6.24mm2 in OFDI group and 6.72mm2 in IVUS group (p=0.20). At 8-month follow-up, in-segment MLA was 4.56mm2 in OFDI group and 4.13mm2 in IVUS group (P for non-inferiority <0.001). During the follow-up (median 4.5 years [1654 days]), incidence rates of major adverse cardiac event were comparable between the two groups (7.4% in OFDI group and 7.3% in IVUS group, hazard ratio 0.96, 95% CI 0.24–3.83, p=0.95). No definite or probable stent thrombosis were documented in both groups.
Conclusion
OFDI-guided PCI demonstrated comparable results in achieving satisfactory imaging surrogates as well as long-term clinical outcomes after newer generation DES implantation as compared to IVUS-guided PCI.
Funding Acknowledgement
Type of funding source: Foundation. Main funding source(s): Suzuken Memorial Foundation
Collapse
Affiliation(s)
- T Muramatsu
- Fujita Health University Hospital, Cardiovascular Center, Department of Cardiology, Toyoake, Japan
| | - M Ishikawa
- Fujita Health University Hospital, Cardiovascular Center, Department of Cardiology, Toyoake, Japan
| | - M Nanasato
- Sakakibara Heart Institute, Department of Cardiology, Fucyu Tokyo, Japan
| | - R Nagasaka
- Fujita Health University Hospital, Cardiovascular Center, Department of Cardiology, Toyoake, Japan
| | - H Takatsu
- Fujita Health University Hospital, Cardiovascular Center, Department of Cardiology, Toyoake, Japan
| | - Y Yoshiki
- Fujita Health University Okazaki Medical Center, Department of Cardiology, Okazaki, Japan
| | - Y Hashimoto
- Fujita Health University Okazaki Medical Center, Department of Cardiology, Okazaki, Japan
| | - M Ohota
- Fujita Health University Hospital, Cardiovascular Center, Department of Cardiology, Toyoake, Japan
| | - H Kamiya
- Gifu Heart Center, Department of Cardiovascular Medicine, Gifu, Japan
| | - Y Yoshida
- Nagoya Daini Red Cross Hospital, Cardiovascular Center, Nagoya, Japan
| | - T Murohara
- Nagoya University Graduate School of Medicine, Department of Cardiology, Nagoya, Japan
| | - Y Ozaki
- Fujita Health University Okazaki Medical Center, Department of Cardiology, Okazaki, Japan
| | - H Izawa
- Fujita Health University Hospital, Cardiovascular Center, Department of Cardiology, Toyoake, Japan
| |
Collapse
|
29
|
Sumida S, Shinohara K, Nishitani T, Ogawa K, Bando T, M Sukegawa A, Ishikawa M, Takada E, Bierwage A, Oyama N. Conceptual design of a collimator for the neutron emission profile monitor in JT-60SA using Monte Carlo simulations. Rev Sci Instrum 2020; 91:113504. [PMID: 33261467 DOI: 10.1063/5.0025902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/19/2020] [Accepted: 11/02/2020] [Indexed: 06/12/2023]
Abstract
Materials and structures of a collimator for a new neutron emission profile monitor in JT-60SA are examined through Monte Carlo simulations using the Monte Carlo N-Particle transport code. First, the shielding properties of various material combinations are compared in order to determine a combination with high shielding performances against both neutrons and gamma-rays. It is found that a collimator consisting of borated polyethylene and lead has a high shielding performance against neutrons. Moreover, a high shielding performance against gamma-rays is obtained when a lead pipe with a radial thickness of 0.01 m is inserted into a collimation tube. Second, we demonstrate that it is possible to improve the spatial resolution to a desired level by installing a thin tubular extension structure that fits into the limited space available between the main collimator block and the tokamak device. Finally, the collimator structures that meet both the targeted spatial resolutions (<10% of the plasma minor radius) and the targeted counting rate (105 cps order) are discussed.
Collapse
Affiliation(s)
- S Sumida
- Naka Fusion Institute, National Institutes for Quantum and Radiological Science and Technology, Naka, Ibaraki 311-0193, Japan
| | - K Shinohara
- Naka Fusion Institute, National Institutes for Quantum and Radiological Science and Technology, Naka, Ibaraki 311-0193, Japan
| | - T Nishitani
- National Institute for Fusion Science, National Institutes of Natural Sciences, Toki, Gifu 509-5292, Japan
| | - K Ogawa
- National Institute for Fusion Science, National Institutes of Natural Sciences, Toki, Gifu 509-5292, Japan
| | - T Bando
- Naka Fusion Institute, National Institutes for Quantum and Radiological Science and Technology, Naka, Ibaraki 311-0193, Japan
| | - A M Sukegawa
- Naka Fusion Institute, National Institutes for Quantum and Radiological Science and Technology, Naka, Ibaraki 311-0193, Japan
| | - M Ishikawa
- Naka Fusion Institute, National Institutes for Quantum and Radiological Science and Technology, Naka, Ibaraki 311-0193, Japan
| | - E Takada
- Department of Electrical and Control Systems Engineering, National Institute of Technology, Toyama College, Toyama, Toyama 939-8630, Japan
| | - A Bierwage
- Rokkasho Fusion Institute, National Institutes for Quantum and Radiological Science and Technology, Rokkasho, Aomori 039-3212, Japan
| | - N Oyama
- Naka Fusion Institute, National Institutes for Quantum and Radiological Science and Technology, Naka, Ibaraki 311-0193, Japan
| |
Collapse
|
30
|
Ohta M, Ozaki Y, Toriya T, Nagasaya R, Takatsu H, Yoshiki Y, Hashimoto Y, Ishikawa M, Kawai H, Muramatsu T, Naruse H, Takahashi H, Ishii J, Izawa H. Five-year major adverse cardiac and cerebrovascular events of patients with lipid core abutting lumen (LCAL) on integrated-backscatter intravascular ultrasound undergoing PCI with current DES. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Percutaneous Coronary Intervention (PCI) using the new generation drug-eluting stent (DES) has been extremely reduced target lesion revascularization (TLR) in recent years. However, a high incidence of non-target lesion-related cardiovascular events in patients undergoing PCI is an important problem to be solved. According to the previous findings, patients with vulnerable plaques particularly have a high recurrence of cardiovascular events. Little studies, however, has been done to examine the relationship between plaque characteristics on intravascular imaging in a target lesion and non-target lesion-related cardiovascular events.
Purpose
The main objective of this study is to investigate the five-year major adverse cardiac and cerebrovascular events (MACCE) of patients with lipid core abutting lumen (LCAL) on integrated backscatter intravascular ultrasound (IB-IVUS) in a target lesion undergoing PCI with current DES.
Methods and results
Between February 2010 and September 2013, in total 780 patients with ischemic heart disease undergoing PCI, 166 target lesions in 166 consecutive patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS) and stable angina pectoris (SAP) undergoing IVUS-guided PCI were studied.
Plaque characteristics in all target lesions were analyzed by three-dimensional IB-IVUS system using the mechanical IVUS catheter. Our previous study has found that LCAL which is defined as a lipid pool directly in contact with the lumen visualizes the thin fibrous cap of less than 75μm on optical coherence tomography (OCT). On the basis of this data, LCAL at minimal lumen area (MLA) site was identified.
In total, 39 patients had lesions with LCAL at MLA site (LCAL(+)), and 127 patients had those without LCAL (LCAL(−)).
The primary endpoint was defined as MACCE, including cardiovascular death, non-fatal myocardial infarction, non-fatal stroke and non-TLR for the new lesion during a median follow up of five years. The MACCE occurred significantly higher in the LCAL(+) than in the LCAL(−) (38.5% vs. 17.3%; p<0.005). And the Kaplan-Meier estimates have shown that the cumulative incidence of MACCE was significantly higher in the LCAL(+) than in the LCAL(−) (log rank test, p=0.041). Additionally, after adjustment for confounders, gender, prior PCI and LCAL was the independent predictors for the MACCE of patients undergoing PCI with current DES.
Furthermore, after adding LCAL to a baseline model with established factors consisting of age, gender, diabetes mellitus, prior PCI and percentage lipid volume on IB-IVUS, the net reclassification (p<0.002) and integrated discrimination improvement (p<0.004) significantly improved compared to baseline model alone.
Conclusions
In this study, it has become clear that LCAL on IB-IVUS is likely to be a surrogate marker of MACCE in patients undergoing PCI with current DES.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- M Ohta
- Fujita Health University, Toyoake, Japan
| | - Y Ozaki
- Fujita Health University, Toyoake, Japan
| | - T Toriya
- Fujita Health University, Toyoake, Japan
| | - R Nagasaya
- Fujita Health University, Toyoake, Japan
| | - H Takatsu
- Fujita Health University, Toyoake, Japan
| | - Y Yoshiki
- Fujita Health University, Toyoake, Japan
| | | | - M Ishikawa
- Sakurabashi-Watanabe Hospital, Cardiology, Osaka, Japan
| | - H Kawai
- Fujita Health University, Toyoake, Japan
| | | | - H Naruse
- Fujita Health University, Toyoake, Japan
| | | | - J Ishii
- Fujita Health University, Toyoake, Japan
| | - H Izawa
- Fujita Health University Second Hospital, Cardiology, Nagoya, Japan
| |
Collapse
|
31
|
Nakajima K, Hamada K, Ito R, Yoshida Y, Sutherland K, Ishikawa M, Ozaki M, Shirato H, Hamada T. Stability of
d
‐luciferin for bioluminescence to detect gene expression in freely moving mice for long durations. LUMINESCENCE 2020; 36:94-98. [DOI: 10.1002/bio.3917] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2020] [Revised: 07/14/2020] [Accepted: 07/20/2020] [Indexed: 11/11/2022]
Affiliation(s)
- Kanako Nakajima
- Department of Pharmaceutical Sciences International University of Health and Welfare Ohtawara Tochigi Japan
| | - Kazuko Hamada
- Department of Pharmaceutical Sciences International University of Health and Welfare Ohtawara Tochigi Japan
| | - Ryoga Ito
- Department of Pharmaceutical Sciences International University of Health and Welfare Ohtawara Tochigi Japan
| | - Yukina Yoshida
- Department of Pharmaceutical Sciences International University of Health and Welfare Ohtawara Tochigi Japan
| | - Kenneth Sutherland
- Global Center for Biomedical Science and Engineering, Faculty of Medicine Hokkaido University Sapporo Hokkaido Japan
| | - Masayori Ishikawa
- Global Center for Biomedical Science and Engineering, Faculty of Medicine Hokkaido University Sapporo Hokkaido Japan
- Faculty of Health Sciences, Hokkaido University Sapporo Hokkaido Japan
| | - Michitaka Ozaki
- Department of Biological Response and Regulation, Faculty of Health Sciences Hokkaido University Sapporo Hokkaido Japan
| | - Hiroki Shirato
- Global Center for Biomedical Science and Engineering, Faculty of Medicine Hokkaido University Sapporo Hokkaido Japan
- Department of Proton Beam Therapy Research Center for Collaborative Projects, Faculty of Medicine Hokkaido University Sapporo Hokkaido Japan
| | - Toshiyuki Hamada
- Department of Pharmaceutical Sciences International University of Health and Welfare Ohtawara Tochigi Japan
- Department of Biological Response and Regulation, Faculty of Health Sciences Hokkaido University Sapporo Hokkaido Japan
- Hakujikai Institute of Gerontology 5‐11‐1, Shikahama, Adachi Ward Tokyo Japan
| |
Collapse
|
32
|
Manzi F, Ishikawa M, Di Dio C, Itakura S, Kanda T, Ishiguro H, Massaro D, Marchetti A. The understanding of congruent and incongruent referential gaze in 17-month-old infants: an eye-tracking study comparing human and robot. Sci Rep 2020; 10:11918. [PMID: 32681110 PMCID: PMC7368080 DOI: 10.1038/s41598-020-69140-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2020] [Accepted: 07/06/2020] [Indexed: 11/09/2022] Open
Abstract
Several studies have shown that the human gaze, but not the robot gaze, has significant effects on infant social cognition and facilitate social engagement. The present study investigates early understanding of the referential nature of gaze by comparing-through the eye-tracking technique-infants' response to human and robot's gaze. Data were acquired on thirty-two 17-month-old infants, watching four video clips, where either a human or a humanoid robot performed an action on a target. The agent's gaze was either turned to the target (congruent) or opposite to it (incongruent). The results generally showed that, independent of the agent, the infants attended longer at the face area compared to the hand and target. Additionally, the effect of referential gaze on infants' attention to the target was greater when infants watched the human compared to the robot's action. These results suggest the presence, in infants, of two distinct levels of gaze-following mechanisms: one recognizing the other as a potential interactive partner, the second recognizing partner's agency. In this study, infants recognized the robot as a potential interactive partner, whereas ascribed agency more readily to the human, thus suggesting that the process of generalizability of gazing behaviour to non-humans is not immediate.
Collapse
Affiliation(s)
- F Manzi
- Research Unit on Theory of Mind, Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy.
| | - M Ishikawa
- School of Graduated Letter, Department of Psychology, Kyoto University, Kyoto, Japan
| | - C Di Dio
- Research Unit on Theory of Mind, Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy
| | - S Itakura
- Centre for Baby Science, Doshisha University, Kyoto, Japan
| | - T Kanda
- Human-Robot Interaction Laboratory, Department of Computer Science, Kyoto University, Kyoto, Japan.,Advanced Telecommunications Research Institute International, IRC/HIL, Keihanna Science City, Kyoto, Japan
| | - H Ishiguro
- Advanced Telecommunications Research Institute International, IRC/HIL, Keihanna Science City, Kyoto, Japan.,Department of Systems Innovation, Osaka University, Toyonaka, Japan
| | - D Massaro
- Research Unit on Theory of Mind, Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy
| | - A Marchetti
- Research Unit on Theory of Mind, Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy
| |
Collapse
|
33
|
Ito R, Hamada K, Kasahara S, Kikuchi Y, Nakajima K, Sutherland K, Shirato H, Ozaki M, Ishikawa M, Hamada T. Mouse
period1
gene expression recording from olfactory bulb under free moving conditions with a portable optic fibre device. LUMINESCENCE 2020; 35:1248-1253. [DOI: 10.1002/bio.3884] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2020] [Revised: 03/30/2020] [Accepted: 05/03/2020] [Indexed: 11/11/2022]
Affiliation(s)
- Ryoga Ito
- Department of Pharmaceutical Sciences International University of Health and Welfare Ohtawara Tochigi Japan
| | - Kazuko Hamada
- Department of Pharmaceutical Sciences International University of Health and Welfare Ohtawara Tochigi Japan
| | - Shigeru Kasahara
- Global Center for Biomedical Science and Engineering, Faculty of Medicine Hokkaido University Sapporo Hokkaido Japan
| | - Yoshihiro Kikuchi
- Department of Pharmaceutical Sciences International University of Health and Welfare Ohtawara Tochigi Japan
| | - Kanako Nakajima
- Department of Pharmaceutical Sciences International University of Health and Welfare Ohtawara Tochigi Japan
| | - Kenneth Sutherland
- Global Center for Biomedical Science and Engineering, Faculty of Medicine Hokkaido University Sapporo Hokkaido Japan
| | - Hiroki Shirato
- Global Center for Biomedical Science and Engineering, Faculty of Medicine Hokkaido University Sapporo Hokkaido Japan
- Department of Proton Beam Therapy, Research Center for Collaborative Projects, Faculty of Medicine Hokkaido University Sapporo Hokkaido Japan
| | - Michitaka Ozaki
- Department of Biological Response and Regulation, Faculty of Health Sciences Hokkaido University Sapporo Hokkaido Japan
| | - Masayori Ishikawa
- Global Center for Biomedical Science and Engineering, Faculty of Medicine Hokkaido University Sapporo Hokkaido Japan
- Faculty of Health Sciences Hokkaido Universtiy Sapporo Hokkaido 060‐0812 Japan
| | - Toshiyuki Hamada
- Department of Pharmaceutical Sciences International University of Health and Welfare Ohtawara Tochigi Japan
- Department of Biological Response and Regulation, Faculty of Health Sciences Hokkaido University Sapporo Hokkaido Japan
- Hakujikai Institute of Gerontology 5‐11‐1, Shikahama, Adachi Ward Tokyo Japan
| |
Collapse
|
34
|
Kusumoto T, Matsuya Y, Baba K, Ogawara R, Akselrod MS, Harrison J, Fomenko V, Kai T, Ishikawa M, Hasegawa S, Kodaira S. Verification of dose estimation of Auger electrons emitted from Cu-64 using a combination of FNTD measurements and Monte Carlo simulations. RADIAT MEAS 2020. [DOI: 10.1016/j.radmeas.2020.106256] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
35
|
Kuga Y, Ogawara R, Ishikawa M. Feasibility study on a novel tiny dosimeter using a barium titanate capacitor. J Radiat Res 2020; 61:34-43. [PMID: 31846039 PMCID: PMC6976862 DOI: 10.1093/jrr/rrz083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/23/2019] [Revised: 06/25/2019] [Accepted: 11/21/2019] [Indexed: 06/10/2023]
Abstract
In our laboratory we have confirmed that the capacitance of barium titanate-based capacitors changes due to radiation. Since a commercially available capacitor is very small and inexpensive, it may be used as a multidimensional dose meter in which a large number of capacitor elements are arranged, or may be embedded in the body and used as an in-vivo dose meter. In this study we examined the usefulness of a dosimeter using the capacitance change of a barium titanate capacitor. As a basic property, it was confirmed that the dose linearity was good. With regard to dose rate characteristics and response to fractionated irradiation, capacitance change due to aging affects measurement accuracy, but online measurement of capacitance change immediately before irradiation can be performed to correct aging effects during irradiation. By doing this, we confirmed that the dose rate characteristics and the response to fractionated radiation are improved.
Collapse
Affiliation(s)
- Yuma Kuga
- Graduate School of Biomedical Science and Engineering, Hokkaido University, N-15 W-7 Kita-ku, Sapporo Hokkaido, 060-8638, Japan
| | - Ryo Ogawara
- National Institutte of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba, 263-8555, Japan
| | - Masayori Ishikawa
- Graduate School of Health Sciences, Hokkaido University, N-12 W-5 Kita-ku, Sapporo Hokkaido, 060-0812, Japan
| |
Collapse
|
36
|
Hirota K, Tanaka T, Iwata N, Ishikawa M. [Real-time Lens Exposure Dose Measurement Using a Scintillator with Optical Fiber Dosimeter during Cardiac Catheter Operation]. Nihon Hoshasen Gijutsu Gakkai Zasshi 2020; 76:817-827. [PMID: 32814737 DOI: 10.6009/jjrt.2020_jsrt_76.8.817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
In recent years, the exposure dose of the operator's eye lens during interventional radiology operations has become a problem. We therefore evaluated the feasibility of real-time lens dose measurement using scintillator with optical fiber (SOF) dosimeter. Given that the SOF dosimeter is calibrated for direct X-rays, we performed a calibration for scattered X-rays to investigate energy dependence and the accuracy of lens dose measurements. The detection limit was calculated using the Kaiser method. The SOF dosimeter and the radiophotoluminescence glass (RPLG) dosimeter were attached to the protective glasses worn by the operator, and the lens exposure dose of the operator during cardiac catheterization was measured. In the phantom experiment, the SOF dosimeter had an error rate of 5.45% based on the measured value of the ionization chamber dosimeter. The sensitivity characteristics of the SOF dosimeter were slightly reduced on the higher side of the effective energy. The difference in sensitivity was related to variations in the additional filter and energy dependency. The sensitivity difference was 18.5% at maximum. Furthermore, when the additional dose was displayed, the influence of noise on long-term measurement was considerable. Using the Kaiser method to obtain the detection limit, the accuracy of the integrated dose had SOF dosimeter error rates of 4.3% to 15.5% with respect to the integrated value of the RPLG dosimeter when calibrated by the ionization chamber dosimeter. The use of the SOF dosimeter allowed for the real-time visualization of the exposure status of the eye lens and measurements with a relatively high accuracy.
Collapse
Affiliation(s)
| | - Takuro Tanaka
- Department of Clinical Radiology, Tottori University Hospital
- Division of Health Sciences, Graduate School of Medical Sciences, Kanazawa University
| | - Naoki Iwata
- Department of Clinical Radiology, Tottori University Hospital
| | | |
Collapse
|
37
|
Razia S, Nakayama K, Nakamura K, Ishibashi T, Ishikawa M, Kyo S. Uterine adenosarcoma in a patient following microwave endometrial ablation: a case report. EUR J GYNAECOL ONCOL 2019. [DOI: 10.12892/ejgo4641.2019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
38
|
Ishikawa M, Nomura M, Miyoshi M, Nishi N, Yokoyama T, Miura H. A self-reported measurement scale on a potential component of competency in the healthcare staff engaged in the prevention and control of non-communicable disease in Fiji. BMC Health Serv Res 2019; 19:838. [PMID: 31727066 PMCID: PMC6857309 DOI: 10.1186/s12913-019-4695-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2018] [Accepted: 10/30/2019] [Indexed: 11/10/2022] Open
Abstract
Background According to the World Health Organization, an estimated 80% or more deaths in Pacific island countries, including Fiji, were related to non-communicable diseases (NCDs). Although competency-based approaches have been effective for developing healthcare workers’ capabilities, there are only a few reports on competency scales of healthcare workers for NCD prevention. We aimed to develop a self-reported measurement scale on a potential component of competency in the healthcare staff engaged in the prevention and control of NCDs in Fiji. Methods There were 378 Ministry of Health and Medical Services staff members working on NCD prevention and control in Fiji included in this study, which was a cross-sectional survey of social factors, working situation factors, and competency. Exploratory factor analysis was conducted to assess potential competency components, whereas Cronbach’s α coefficient and analysis of variance were used to assess the validity and reliability of the scale items, respectively. Multivariate regression analyses were conducted to analyze the respondents’ factor scores relative to social status and work situations. Results The factor analysis revealed 16 items that identified competency in four work types: 1) work management, 2) monitoring and evaluation, 3) community partnership, and 4) community diagnosis. The monitoring and evaluation roles were related to ethnic background, community partnership was related to religion, and community diagnosis was related to academic qualifications. Conclusions Based on the results, we developed a competency scale for the four work types. This scale can help healthcare workers engage in better management of residents with NCDs in Fiji.
Collapse
Affiliation(s)
- M Ishikawa
- Department of Health Promotion, National Institute of Public Health, 2-3-6 Minami, Wako, Saitama, 351-0197, Japan.
| | - M Nomura
- Department of International Health and Collaboration, National Institute of Public Health, 3-6 Wako, Saitama, 351-0197, Japan
| | - M Miyoshi
- Department of Nutrition, Faculty of Health Sciences, Aomori University of Health and Welfare, 58-1, Mase, Hamadate, Aomori, 030-8505, Japan
| | - N Nishi
- International Center for Nutrition and Information, National Institutes of Biomedical Innovation, Health and Nutrition, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8636, Japan
| | - T Yokoyama
- Department of Health Promotion, National Institute of Public Health, 2-3-6 Minami, Wako, Saitama, 351-0197, Japan
| | - H Miura
- Department of International Health and Collaboration, National Institute of Public Health, 3-6 Wako, Saitama, 351-0197, Japan
| |
Collapse
|
39
|
Nagata Y, Kinoshita C, Ishimoto U, Kano T, Ishikawa M, Mikuni H, Nakatsuka K, Harada K, Nishimura T, Noguchi M, Sawada R, Amano K, Saruta M. Details of response with first-line gemcitabine and nab-paclitaxel therapy in patients with advanced pancreatic cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz422.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
40
|
Kuno I, Takayanagi D, Yoshida H, Hirose S, Murakami N, Uno M, Ishikawa M, Matsuda M, Asami Y, Shimada Y, Okuma K, Kohno T, Itami J, Shiraishi K, Kato T. Impact of genomic alterations and HPV genotypes on clinical outcomes of Japanese patients with locally advanced cervical cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz426.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
41
|
Ohota M, Ozaki Y, Nagasaka R, Tatatsu H, Yoshiki Y, Hashimoto Y, Ishikawa M, Muramatsu T. P3388Five year outcomes of patients with lipid rich plaque detected three-dimensional Integrated-Backscatter intravascular ultrasound (IB-IVUS) in target lesion after second generation DES implantation. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Elective percutaneous coronary intervention (PCI) using second generation drug-eluting stent (DES) has been dramatically reduced restenosis rate. Recently, it has been reported that plaque characterization in nontarget lesion is associated with cardio-vascular events in ischemic heart disease patients undergoing elective PCI. However, it is unclear whether plaque characterization in target lesion is predictor of MACEs (major adverse cardiac events) after elective PCI.
Purposes
The aim of this study is whether plaque characterization detected integrated-backscatter intravascular ultrasound (IB-IVUS) in the target lesion is associated with MACEs in patients with PCI after second generation DES implantation.
Methods and results
Of 700 patients with ischemic heart disease, 552 patients were excluded for chronic totally occlusion, severe calcification hindering precise intracoronary imaging, tortuous lesions, ostial or left main stem lesions and ST-elevated myocardial infarction patients. Finally, 148 consecutive patients who consented to repeated IB-IVUS prior to undergoing elective PCI were recruited in the study.Plaque characterization in target lesion was identified for three-dimensional IB-IVUS technology using the mechanical IVUS catheter (ViewIT, 40 MHz, 2.5 Fr; Terumo, Tokyo, Japan). The median of percentage lipid volume in all target lesions was 47.6%. Furthermore, lipid rich plaque (LRP) group was defined as the lesions consisting of percentage lipid volume greater than the median. And, non-lipid rich plaque (non-LRP) group was defined as the lesions consisting of percentage lipid volume less than the median. MACEs were defined as cardiovascular death, target vessel myocardial infarction, target lesion revascularization and stent thrombosis. The median of follow up period was 60 months. Of the 148 patients, 106 patients had stable angina pectoris. The remaining 42 patients are acute coronary syndrome (NSTE-ACS). 74 patients were classified LRP groups and 74 patients were non-LRP groups. No significant differences were observed between the two groups with respect to age, sex and coronary risk factors. While plaque and vessel volume were greater in the LRP group (216.9±116.3mm3, p<0.001) than non-LRP group (322.5±144.0mm3, p p<0.001). Remodeling index was greater in LRP group (1.02±0.18) than non-LRP group (0.93±0.18, p<0.003). Although MACEs were no significant differences between the two groups, the number of MACEs tend to be more in patients with LRP group (8.1±27.4%) than small lipid group (2.7±16.3, p<0.147). Especially, cardiac death tend to be more in LRP group (6.7±25.2% than non-LRP group (1.3±11.6, p<0.096).
Conclusions
In conclusion, lipid rich plaque detected by three dimensional IB-IVUS system in target lesion with patients undergoing elective PCI may be associated with clinical outcomes for five years after second generation DES implantation.
Acknowledgement/Funding
None
Collapse
Affiliation(s)
- M Ohota
- Fujita Health University, Toyoake, Japan
| | - Y Ozaki
- Fujita Health University, Toyoake, Japan
| | - R Nagasaka
- Fujita Health University, Toyoake, Japan
| | - H Tatatsu
- Fujita Health University, Toyoake, Japan
| | - Y Yoshiki
- Fujita Health University, Toyoake, Japan
| | | | - M Ishikawa
- Fujita Health University, Toyoake, Japan
| | | |
Collapse
|
42
|
Ishikawa T, Abe K, Ishikawa M, Yoshida K, Watanabe T, Tsutsui H. P4691Chronic blockade of toll-like receptor 9 ameliorated pulmonary arterial hypertension by reducing perivascular inflammation in rats. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.1072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background/Introduction
Perivascular inflammation plays an important role in the pathogenesis of pulmonary arterial hypertension (PAH). Recent studies have demonstrated that damaged mitochondrial DNA induces sterile inflammation by activating toll-like receptor (TLR)9 in spontaneous hypertensive rats. However, it remains unclear whether TLR9 is involved in perivascular inflammation and subsequent development of PAH.
Purpose
The purpose of the present study is to investigate whether chronic inhibition of TLR9 can ameliorate monocrotaline (MCT)-induced PAH in rats.
Methods
Male Sprague-Dawley rats were injected with MCT (60 mg/kg). First, we conducted immunohistochemistory to examine which cell types express TLR9 in lungs of normal rats and MCT-exposed rats. Second, we extracted cell-free DNA from plasma of rats and amplified genes of COX2 by real-time PCR to detect circulating cell-free mitochondrial DNA, a ligand of TLR9. Third, the administration of a selective TLR9 inhibitor (E6446, 10mg/kg/day, drinking water) or non-selective TLR9 inhibitor (chloroquine: 50mg/kg/day, ip) started three days before MCT injection and sacrificed on day 21. We assessed hemodynamic data and histopathological analysis (EVG stain for medial wall thickness (MWT) in pulmonary arteries (outer diameter: 50 ∼ 100 μm) and CD68 for macrophage accumulation around pulmonary arteries (outer diameter: <50 μm)), and measured the levels of interleukin-6 (IL-6) in lungs by real time PCR. Finally, we investigated survival rate in the reversal protocol, where we started the administration of E6446 on day 14.
Results
TLR9 was expressed dominantly in pulmonary endothelial cells and macrophages in the lungs of both normal rats and MCT-exposed rats. Compared with normal rats, MCT-exposed rats showed increased gene expression of COX2 (0.048±0.001 vs. 0.052±0.001 expressed by 1/Ct) in plasma on day 14. MCT-exposed rats also had increased right ventricular systolic pressure (RVSP: 21±1 vs. 60±2 mmHg), total pulmonary vascular resistance index (TPRI: 0.07±0.01 vs. 0.43±0.02 mmHg/min/mL/kg), MWT (0.07±0.01 vs. 0.26±0,02) and accumulation of macrophages (1.6±0.3 vs. 20.0±1.7 cells/HPF) on day 21. In the prevention protocol, either E6446 or chloroquine significantly prevented the elevations of RVSP (49±4 or 48±3 mmHg) and TPRI (0.29±0.04 or 0.27±0.03 mmHg/min/mL/kg) with reducing MWT (0.18±0.01 or 0.18±0.01) and macrophage accumulation (9.7±1.3 or 9.8±2.5 cell/HPF) on day 21. In addition, these drugs significantly reduced the levels of IL-6 mRNA compared with MCT group (4.4±1.0 or 4.8±1.4 vs. 11.9±1.0). In the reversal protocol, the treatment of E6446 had significantly increased the survival rate (50 vs. 10%).
Conclusions
TLR9 largely contributes to the development of PAH by reducing perivascular inflammation. Inhibition of TLR9 could be a novel therapeutic target for PAH.
Collapse
Affiliation(s)
- T Ishikawa
- Kyushu University Hospital, Fukuoka, Japan
| | - K Abe
- Kyushu University Hospital, Fukuoka, Japan
| | - M Ishikawa
- Kyushu University Hospital, Fukuoka, Japan
| | - K Yoshida
- Kyushu University Hospital, Fukuoka, Japan
| | - T Watanabe
- Kyushu University Hospital, Fukuoka, Japan
| | - H Tsutsui
- Kyushu University Hospital, Fukuoka, Japan
| |
Collapse
|
43
|
Takagi S, Yaegashi T, Ishikawa M. Relationship Between Tube Voltage and Physical Image Quality of Pulmonary Nodules on Chest Radiographs Obtained Using the Bone-Suppression Technique. Acad Radiol 2019; 26:e174-e179. [PMID: 30269955 DOI: 10.1016/j.acra.2018.08.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2018] [Revised: 08/08/2018] [Accepted: 08/27/2018] [Indexed: 11/18/2022]
Abstract
RATIONALE AND OBJECTIVES Image quality of chest radiographs is affected by tube voltage. This study aimed to clarify the relationship between tube voltage and physical image quality of pulmonary nodules on bone-suppressed chest radiographs. MATERIALS AND METHODS An anthropomorphic chest phantom and a spherical simulated nodule, with a 12-mm diameter and approximately +100 Hounsfield units were used. The lung field of the phantom was divided into three areas, based on the overlap with the ribs in the chest radiograph. Ten positions of the simulated nodule were defined in each area. One hundred and twenty chest radiographs were acquired using four tube voltages (70 kVp, 90 kVp, 110 kVp, and 130 kVp) for a total of 30 nodule positions and were processed to create bone-suppressed images. Differences in contrast and contrast-to-noise ratio (CNR) were analyzed for all pairs of the four tube voltages using a two-sided Wilcoxon signed-rank test. RESULTS In the area not overlapping with ribs, a statistically significant difference was observed only in contrast between tube voltage of 70 kVp and 90 kVp (p = 0.01). In the area overlapping with one or two ribs, the contrast and CNR tended to be higher at a lower tube voltage. In particular, the p values between the contrast at 70 kVp and that at the other three tube voltage settings were less than 0.01. CONCLUSION For a relatively dense nodule, the contrast and CNR in the bone-suppressed chest radiograph were significantly improved with lower tube voltage in the lung field overlapping with the ribs.
Collapse
Affiliation(s)
- Satoshi Takagi
- Faculty of Health Sciences, Hokkaido University, Kita 12, Nishi 5, Kita-ku, Sapporo, Hokkaido 060-0812, Japan.
| | - Tatsuya Yaegashi
- Department of Radiology, Hokkaido Memorial Hospital of Urology, 1-25, Kita 41, Higashi 1, Higashi-ku, Sapporo, Hokkaido 007-0841, Japan
| | - Masayori Ishikawa
- Faculty of Health Sciences, Hokkaido University, Kita 12, Nishi 5, Kita-ku, Sapporo, Hokkaido 060-0812, Japan
| |
Collapse
|
44
|
Sanuki K, Nakayama K, Nakamura K, Ishibashi T, Ishikawa M, Ishikawa N, Kyo S. Rapidly enlarged uterus following microwave endometrial ablation: a case report. CLIN EXP OBSTET GYN 2019. [DOI: 10.12891/ceog4365.2019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
45
|
He B, Chiba Y, Li H, de Vega S, Tanaka K, Yoshizaki K, Ishijima M, Yuasa K, Ishikawa M, Rhodes C, Sakai K, Zhang P, Fukumoto S, Zhou X, Yamada Y. Identification of the Novel Tooth-Specific Transcription Factor AmeloD. J Dent Res 2018; 98:234-241. [PMID: 30426815 DOI: 10.1177/0022034518808254] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Basic-helix-loop-helix (bHLH) transcription factors play an important role in various organs' development; however, a tooth-specific bHLH factor has not been reported. In this study, we identified a novel tooth-specific bHLH transcription factor, which we named AmeloD, by screening a tooth germ complementary DNA (cDNA) library using a yeast 2-hybrid system. AmeloD was mapped onto the mouse chromosome 1q32. Phylogenetic analysis showed that AmeloD belongs to the achaete-scute complex-like ( ASCL) gene family and is a homologue of ASCL5. AmeloD was uniquely expressed in the inner enamel epithelium (IEE), but its expression was suppressed after IEE cell differentiation into ameloblasts. Furthermore, AmeloD expression showed an inverse expression pattern with the epithelial cell-specific cell-cell adhesion molecule E-cadherin in the dental epithelium. Overexpression of AmeloD in dental epithelial cell line CLDE cells resulted in E-cadherin suppression. We found that AmeloD bound to E-box cis-regulatory elements in the proximal promoter region of the E-cadherin gene. These results reveal that AmeloD functions as a suppressor of E-cadherin transcription in IEE cells. Our study demonstrated that AmeloD is a novel tooth-specific bHLH transcription factor that may regulate tooth development through the suppression of E-cadherin in IEE cells.
Collapse
Affiliation(s)
- B He
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.,2 State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.,3 Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
| | - Y Chiba
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.,4 Division of Pediatric Dentistry, Department of Oral Health and Development Sciences, Graduate School of Dentistry, Tohoku University, Sendai, Japan
| | - H Li
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.,5 Lifecare Acupuncture and Alternative Medicine Center, Colleyville, TX, USA
| | - S de Vega
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.,6 Department of Pathophysiology for Locomotive and Neoplastic Diseases, Graduate School of Medicine, Juntendo University, Tokyo, Japan
| | - K Tanaka
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.,7 Department of Orthopedic Surgery, Oita University, Oita, Japan
| | - K Yoshizaki
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.,8 Division of Oral Health, Growth and Development, Faculty of Dental Science, Kyushu University, Fukuoka, Japan
| | - M Ishijima
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.,9 Department of Medicine for Orthopedics and Motor Organ, Graduate School of Medicine, Juntendo University, Tokyo, Japan
| | - K Yuasa
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.,10 Pediatric Dentistry, St. Mary's Hospital, Kurume, Japan
| | - M Ishikawa
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.,11 Division of Operative Dentistry, Laboratory of Cell and Department of Restorative Dentistry, Graduate School of Dentistry, Tohoku University, Sendai, Japan
| | - C Rhodes
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
| | - K Sakai
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.,12 Department of Oral and Maxillofacial Surgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan
| | - P Zhang
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
| | - S Fukumoto
- 4 Division of Pediatric Dentistry, Department of Oral Health and Development Sciences, Graduate School of Dentistry, Tohoku University, Sendai, Japan
| | - X Zhou
- 2 State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - Y Yamada
- 1 Molecular Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
| |
Collapse
|
46
|
Korekawa A, Akasaka E, Rokunohe D, Fukui T, Kaneko T, Sawamura D, Ishikawa M, Yamamoto T, Nakano H. Nagashima-type palmoplantar keratoderma and malignant melanoma in Japanese patients. Br J Dermatol 2018; 180:415-416. [PMID: 30256384 DOI: 10.1111/bjd.17251] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- A Korekawa
- Department of Dermatology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan
| | - E Akasaka
- Department of Dermatology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan
| | - D Rokunohe
- Department of Dermatology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan
| | - T Fukui
- Department of Dermatology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan
| | - T Kaneko
- Department of Dermatology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan
| | - D Sawamura
- Department of Dermatology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan
| | - M Ishikawa
- Department of Dermatology, Fukushima Medical University School of Medicine, Fukushima, Japan
| | - T Yamamoto
- Department of Dermatology, Fukushima Medical University School of Medicine, Fukushima, Japan
| | - H Nakano
- Department of Dermatology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan
| |
Collapse
|
47
|
Miura T, Ishikawa M, Mori T, Hanami Y, Ohtsuka M, Yamamoto T. Huge Squamous Cell Carcinoma Arising on Severe Hidradenitis Suppurativa. Actas Dermo-Sifiliográficas (English Edition) 2018. [DOI: 10.1016/j.adengl.2018.07.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
48
|
Kita S, Takashima A, Hirano H, Aoki M, Imazeki H, Ishikawa M, Shoji H, Honma Y, Iwasa S, Okita N, Kato K, Nagashima K, Boku N. CT image features of peritoneal metastasis and outcomes of the advanced gastric cancer patients receiving second-line chemotherapy. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy432.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
49
|
Kawai H, Ohta M, Motoyama S, Hashimoto Y, Nagahara Y, Hoshino M, Miyajima K, Ishikawa M, Okumura M, Naruse H, Takahashi H, Ishii J, Muramatsu T, Sarai M, Ozaki Y. 6182Does myocardial bridge assessed by coronary CT angiography predict vasospasm of left anterior descending? Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.6182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- H Kawai
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - M Ohta
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - S Motoyama
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - Y Hashimoto
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - Y Nagahara
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - M Hoshino
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - K Miyajima
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - M Ishikawa
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - M Okumura
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - H Naruse
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - H Takahashi
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - J Ishii
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - T Muramatsu
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - M Sarai
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| | - Y Ozaki
- Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan
| |
Collapse
|
50
|
Miura T, Ishikawa M, Mori T, Hanami Y, Ohtsuka M, Yamamoto T. Huge Squamous Cell Carcinoma Arising on Severe Hidradenitis Suppurativa. Actas Dermosifiliogr (Engl Ed) 2018; 109:828. [PMID: 30072021 DOI: 10.1016/j.ad.2017.11.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2017] [Revised: 11/25/2017] [Accepted: 11/27/2017] [Indexed: 10/28/2022] Open
Affiliation(s)
- T Miura
- Unidad de Dermatología, Facultad de Medicina, Universidad de Fukushima, Fukushima, Japón.
| | - M Ishikawa
- Unidad de Dermatología, Facultad de Medicina, Universidad de Fukushima, Fukushima, Japón
| | - T Mori
- Unidad de Dermatología, Facultad de Medicina, Universidad de Fukushima, Fukushima, Japón
| | - Y Hanami
- Unidad de Dermatología, Facultad de Medicina, Universidad de Fukushima, Fukushima, Japón
| | - M Ohtsuka
- Unidad de Dermatología, Facultad de Medicina, Universidad de Fukushima, Fukushima, Japón
| | - T Yamamoto
- Unidad de Dermatología, Facultad de Medicina, Universidad de Fukushima, Fukushima, Japón
| |
Collapse
|